WO2022044781A1 - Gel composition - Google Patents

Gel composition Download PDF

Info

Publication number
WO2022044781A1
WO2022044781A1 PCT/JP2021/029367 JP2021029367W WO2022044781A1 WO 2022044781 A1 WO2022044781 A1 WO 2022044781A1 JP 2021029367 W JP2021029367 W JP 2021029367W WO 2022044781 A1 WO2022044781 A1 WO 2022044781A1
Authority
WO
WIPO (PCT)
Prior art keywords
hyaluronic acid
gel
mass
thickener
composition
Prior art date
Application number
PCT/JP2021/029367
Other languages
French (fr)
Japanese (ja)
Inventor
俊輔 徳永
陽子 橋爪
友紀奈 倉田
慶子 平野
Original Assignee
日本コルマー株式会社
キユーピー株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本コルマー株式会社, キユーピー株式会社 filed Critical 日本コルマー株式会社
Publication of WO2022044781A1 publication Critical patent/WO2022044781A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to a gel-like composition.
  • Hyaluronic acid is a linear high molecular weight polysaccharide with a molecular weight of tens of thousands to millions, in which N-acetylglucosamine and D-glucuronic acid are alternately bound, which was isolated and identified from bovine vitreous by Meyer et al. In 1934. It is widely distributed in the living body and is present in connective tissues and organs such as skin, joint fluid, blood vessels, brain and cartilage. Hyaluronic acid has high water retention, is viscous due to its water retention capacity, exerts a cell retention function, and functions to maintain the flexibility of tissues. Utilizing this property, hyaluronic acid and hyaluronic acid derivatives are widely used as raw materials for pharmaceuticals, cosmetics, and foods. For example, cosmetics containing hyaluronic acid form a film containing water on the surface of the skin, have the effect of preventing the evaporation of water from the skin, and are useful for maintaining the moisturized state of the skin.
  • a highly viscous gel-like composition containing hyaluronic acid or the like having a high concentration of 0.2% by mass or more which can be used as an all-in-one cosmetic and more positively utilizes the characteristics of hyaluronic acid.
  • the high-viscosity gel-like composition containing a high concentration of hyaluronic acid and the like has a problem that the stability over time is poor, the gel becomes non-uniform over time, and it is easy to be fooled.
  • Patent Document 1 contains 0.01% by mass or more and 5% by mass or less of a thickener, and 0.1 parts or more and 5 parts or more of modified hyaluronic acid containing a carboxymethyl group and / or a salt thereof with respect to 1 part of the thickener.
  • the gel-like cosmetics containing less than a portion are described. However, since this gel-like cosmetic contains a high concentration of hyaluronic acid and the like, its stability over time is not sufficient, and there is the above problem.
  • Patent Documents 2 and 3 describe gel-like compositions containing hyaluronic acid and the like, using an associative thickener.
  • Patent Documents 1 to 3 do not describe the use of an anionic polymer compound thickener and an associative thickener in combination as a thickener, and there are examples in which these are used in combination. do not do.
  • the subject of the present invention is hyaluronic acid having a high concentration of 0.2% by mass or more, which has stability over time, does not have gel inhomogeneity over time, is less likely to be fooled, and has an excellent usability. It is an object of the present invention to provide a highly viscous gel-like composition containing.
  • the present inventors have made a case where only (B) anionic polymer compound thickener is used as the thickener. And (C) When only the associative thickener was used, the obtained gel-like composition containing a high concentration of hyaluronic acid and the like was not stable over time, but (B) was highly anionic.
  • the molecular compound thickener and the (C) associative thickener are combined in a mass ratio of 5: 1 to 0.15: 1, a high concentration of 0.2% by mass or more of hyaluronic acid or the like is contained.
  • the present invention has been completed by finding that the gel-like composition having a viscosity unexpectedly has stability over time, does not cause non-uniformity of the gel over time, and is less likely to be fooled.
  • the present invention is as follows. [1] (A) A gel-like composition containing 0.2% by mass or more of hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof and having a viscosity of 15,000 to 60,000 mPa ⁇ s.
  • the gel-like composition contains (B) anionic polymer compound thickener in an amount of 0.1% by mass or more and (C) an associative thickener in an amount of 0.05% by mass or more.
  • the (B) anionic polymer compound thickener is an anionic polymer compound thickener other than (A) hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof.
  • a gel-like composition in which the mass ratio of the (B) anionic polymer compound thickener to the (C) associative thickener is 5: 1 to 0.15: 1.
  • the gel-like composition of the present invention has stability over time, does not have gel non-uniformity over time, is less likely to be fooled, spreads well on the skin, is not sticky, and is excellent in usability. There is.
  • the present invention is a gel-like composition containing (A) hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof in an amount of 0.2% by mass or more and having a viscosity of 15,000 to 60,000 mPa ⁇ s.
  • the gel-like composition contains (B) an anionic polymer compound thickener in an amount of 0.1% by mass or more, (C) an associative thickener in an amount of 0.05% by mass or more, and (B) an anionic polymer.
  • the present invention relates to a gel-like composition in which the mass ratio of the compound thickener to the (C) associative thickener is 5: 1 to 0.15: 1.
  • hyaluronic acid those extracted from animal tissues, those produced by a fermentation method by culturing microorganisms, and the like are known, and commercially available hyaluronic acid may be appropriately used.
  • the average molecular weight is 500,000 to 3,000,000.
  • those having a high molecular weight, those having a high molecular weight, those having an average molecular weight of 10,000 or less, and the like can be used.
  • Low-molecular-weight hyaluronic acid is produced, for example, by dissolving high-molecular-weight hyaluronic acid in a buffer solution, adding hyaluronidase, incubating for several days, inactivating the enzyme, and then producing (Japanese Patent Laid-Open No. 10-195107). It is produced by using a method of hydrolyzing hyaluronic acid with an acid or the like.
  • the average molecular weight of hyaluronic acid and / or hyaluronic acid derivatives or salts thereof specified in the present invention can be measured by the following method.
  • a calibration curve is prepared from the retention time of a plurality of hyaluronic acids (reference substances) having known molecular weights by liquid chromatography analysis using a gel filtration column.
  • hyaluronic acid and / or hyaluronic acid derivatives or salts thereof to be measured are analyzed by liquid chromatography and the molecular weight is determined using the above calibration curve to obtain hyaluronic acid and / or hyaluronic acid derivatives or salts thereof.
  • the molecular weight of can be determined.
  • Examples of the liquid chromatography analyzer that can be used for liquid chromatography analysis include Waters Alliance 2690 HPLC Separations Module (Waters), Waters Alliance 2695 HPLC Separations Module (Waters), 1200 Agilents. ).
  • Examples of the column that can be used for liquid chromatography analysis include a column for ligand exchange chromatography manufactured by shodex (ligand exchange mode + size exclusion mode), model name "SUGAR KS-801", and the like. "SUGAR KS-802”, “SUGAR KS-803”, “SUGAR KS-804", “SUGAR KS-805", “SUGAR KS-806”, “SUGAR KS-807", and TOSOH size exclusion chromatography columns, The model name "TSKgel GMPW” can be mentioned.
  • hyaluronic acid derivative examples include derivatives obtained by etherifying, esterifying, acetylating, amidating, acetalizing, and ketalizing the hydroxyl group and carboxyl group of hyaluronic acid.
  • a cationized hyaluronic acid having a quaternary ammonium group-containing group WO2008 / 133267
  • a modified hyaluronic acid containing a glycerin skeleton-containing group WO2011 / 102462
  • WO2016 carboxymethyl group-containing modified hyaluronic acid
  • hyaluronic acid and the hyaluronic acid derivative may be salts such as sodium salt, potassium salt, calcium salt, magnesium salt, ammonium salt, basic amino acid salt and zinc salt.
  • the hyaluronic acid and / or the hyaluronic acid derivative a commercially available hyaluronic acid and / or the hyaluronic acid derivative may be appropriately used. Since a gel-like composition containing a high concentration of hyaluronic acid or the like can be stabilized over time, the hyaluronic acid and / or the hyaluronic acid derivative has an average molecular weight of 500,000 or more and 2 million or less.
  • the hyaluronic acid and / or the hyaluronic acid derivative includes two or more hyaluronic acid and / or hyaluronic acid derivatives having an average molecular weight of 500,000 or more and 2 million or less, and hyaluronic acid and / or hyaluronic acid derivatives having an average molecular weight of 10,000 or less.
  • the hyaluronic acid and / or hyaluronic acid derivative contains a medium-high molecular weight hyaluronic acid having an average molecular weight of 500,000 or more and 2 million or less, a low-molecular-weight hyaluronic acid having an average molecular weight of 10,000 or less, and / or a hyaluronic acid derivative, and a quaternary ammonium group.
  • a combination thereof is also preferable (Japanese Patent Laid-Open No. 2016-166133).
  • Hyaluronic acid and / or hyaluronic acid derivatives having an average molecular weight of 500,000 or more and 2 million or less have a property of staying on the skin surface and preventing water from evaporating from the skin surface, and thus exhibit a continuous skin moisturizing effect.
  • Examples of the low molecular weight hyaluronic acid and / or hyaluronic acid derivative having an average molecular weight of 10,000 or less include those having an average molecular weight of 800 or more and 10,000 or less and 1,000 or more and 10,000 or less.
  • This low-molecular-weight hyaluronic acid and / or hyaluronic acid derivative has a high permeability to the skin and has a property of improving the moisturization of the stratum corneum, and thus exhibits a continuous skin moisturizing effect.
  • the cationized hyaluronic acid derivative having a quaternary ammonium group-containing group more preferably has a cationization degree of 0.15 to 0.6, and more preferably has a cationization degree of 0.15 to 0.4. Things can be mentioned.
  • the degree of cationization refers to the number of quaternary ammonium group-containing groups per disaccharide, which is a constituent unit of hyaluronic acid, and is determined by a conventional method or a semi-micro Kjeldahl method. This cationized hyaluronic acid exerts a long-lasting moisturizing effect on the skin.
  • the "carboxymethyl group" of the modified hyaluronic acid derivative containing a carboxymethyl group means a group represented by "-CH 2 - CO 2 H" or "-CH 2 -CO 2- ", and at least one. Hyaluronic acid in which a carboxymethyl group is introduced.
  • the modified hyaluronic acid derivative containing a carboxymethyl group more preferably has a carboxymethylation rate of 5% or more and 200% or less with respect to the disaccharide unit constituting hyaluronic acid, and more preferably with respect to the disaccharide unit constituting hyaluronic acid. Examples thereof include those having a carboxymethylation rate of 60% or more and 200% or less.
  • the disaccharide unit constituting hyaluronic acid refers to one unit composed of adjacently bonded disaccharides (glucuronic acid and N-acetylglucosamine) constituting hyaluronic acid, and is a disaccharide unit constituting hyaluronic acid.
  • the carboxymethylation rate with respect to 1 unit is the number of carboxymethyl groups contained in the 1 unit, and more specifically, when the 1 unit is 100%, the 1 unit is related to the 1 unit. The ratio (%) of the number of carboxymethyl groups contained in the unit.
  • This modified hyaluronic acid derivative containing a carboxymethyl group exerts a long-lasting moisturizing effect on the skin.
  • the modified hyaluronic acid containing a glycerin skeleton-containing group is preferably of the formula: -O-CH 2 -CHOH-CH 2 -OR 1 (where R 1 represents a linear or branched alkyl or alkenyl). It is a modified hyaluronic acid containing a glycerin skeleton-containing group represented.
  • This modified hyaluronic acid has the property of repairing the lamellar structure composed of the aqueous layer and the lipid layer and improving the barrier function repairing effect of the skin, and thus exerts a continuous skin moisturizing effect.
  • Zinc hyaluronic acid is a complex formed by the interaction of zinc ions with carboxyl ions derived from the carboxyl groups constituting hyaluronic acid.
  • Preferred zinc hyaluronates have a zinc content of 55 to 100 mg per gram, more preferably 60 to 80 mg.
  • Zinc hyaluronate exerts a long-lasting moisturizing effect on the skin.
  • the gel-like composition of the present invention contains 0.2% by mass or more of hyaluronic acid and / or a hyaluronic acid derivative. Preferred contents include 0.2 to 5% by mass, more preferably 0.25 to 3% by mass, and further preferably 0.3 to 2% by mass.
  • 5% by mass or more of hyaluronic acid and / or a hyaluronic acid derivative is contained in the gel-like composition of the present invention, the viscosity of the gel-like composition becomes high, the stability over time becomes insufficient, and over time. Gel non-uniformity may occur.
  • hyaluronic acid and / or hyaluronic acid derivatives or salts thereof those having an average molecular weight of 500,000 to 2,000,000 are preferably contained in an amount of 0.1% by mass or more. .. When it is contained in an amount of 0.1% by mass or more, it stays on the skin surface and has a property of preventing water from evaporating from the skin surface, so that a continuous skin moisturizing effect is exhibited.
  • the more preferable content is 0.1 to 3% by mass, more preferably 0.1 to 1% by mass, and even more preferably 0.1 to 0.2% by mass.
  • aluronic acid and / or hyaluronic acid derivatives or salts thereof those having an average molecular weight of 10,000 or less are preferably contained in an amount of 0.1% by mass or more.
  • it When it is contained in an amount of 0.1% by mass or more, it has a high permeability to the skin and has a property of improving the moisturization of the stratum corneum, so that a continuous skin moisturizing effect is exhibited.
  • More preferable content is 0.1 to 3% by mass or more, further preferably 0.1 to 1% by mass, and even more preferably 0.1 to 0.25% by mass. ..
  • the anionic polymer compound thickener is an anionic polymer compound thickener other than (A) hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof, and is, for example, from a carboxy group, a sulfo group, a phospho group, or the like. It is a polymer compound having a selected anionic group in the molecule, and may be a synthetic polymer or a natural polymer. Preferably, the anionic polymer compound thickener has a carboxy group in the molecule.
  • anionic synthetic polymer compound thickener examples include unsaturated monocarboxylic acid-based monomers (acrylic acid, methacrylic acid, clonic acid, neutralized products of these acids, partially neutralized products, etc.) and unsaturated dicarboxylic acids.
  • Acid-based monomers maleic acid, fumaric acid, itaconic acid, citraconic acid, neutralized products of these acids, partially neutralized products, etc.
  • unsaturated sulfonic acid-based monomers vinyl sulfonic acid, allyl sulfonic acid, methacrylic sulfone, etc.
  • Anionic natural polymer compound thickeners include pectic acid, alginic acid, agar, carrageenan, fucoidan, heparin, gellan gum, native gellan gum, xanthan gum, dextran gum, arabic rubber, carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxymethyl starch, Examples thereof include carboxymethyl dextran, polyglutamic acid, succinylated collagen, carboxymethyl chitin, succinylated chitosan, sodium cellulose sulfate, gelatin, mucin, dextran and the like.
  • Preferred anionic polymer compound thickeners include anionic synthetic polymer compound thickeners. More preferably, an acrylic acid-based anionic polymer compound thickener such as a (meth) acrylic acid / alkyl (meth) acrylic acid copolymer is mentioned, and more preferably, an acrylic acid / alkyl methacrylate copolymer is mentioned. And even more preferably (Acrylate / alkyl acrylate (10 to 30 carbon atoms)) crosspolymers.
  • the gel-like composition contains 0.1% by mass or more of an anionic polymer compound thickener. Preferred contents include 0.1 to 2% by mass, more preferably 0.15 to 1% by mass, and further preferably 0.2 to 0.5% by mass.
  • Associative thickeners are thickeners that contain both hydrophilic and hydrophobic areas.
  • a thickener having a hydrophobic region containing at least one C8-36 fat chain and a hydrophilic region and at least one hydrophilic region can be mentioned.
  • Associative thickeners include, for example, those defined in the Encyclopedia of Polymer Science and Engineering, 2nd Edition, 17, 772-779. Hydrophobic regions can bind to hydrophobic moieties and hydrophilic regions can bind to hydrophilic moieties.
  • the associative thickener forms a network (network structure) by these bonds, that is, by associating the hydrophobic regions with each other, and further by associating the hydrophobic regions with other hydrophobic substances. , Thickening action is exhibited.
  • Examples of the associative thickener include those described in Special Table 2015-514788, Special Table 2017-310649, Special Table 2016-591159, Special Table 2005-500397, WO2011 / 162421, WO2018 / 088312 and the like.
  • Examples of associative thickeners include: (A) Nonionic amphipathic polymer containing at least one C8-36 fatty chain and at least one hydrophilic unit; (B) An anionic amphipathic polymer containing at least one hydrophilic unit and at least one unit having a C8-36 fatty chain; (C) A cationic amphipathic polymer containing at least one hydrophilic unit and at least one unit having a C8-36 fatty chain; (D) An amphoteric amphoteric polymer containing at least one hydrophilic unit and at least one unit having a C8-36 fatty chain.
  • nonionic amphipathic polymers are preferred.
  • examples of the (a) nonionic amphipathic polymer include the following. (1) Cellulose modified with a group having at least one C8-36 fatty chain (hydrophobic modified alkyl cellulose); (2) Urethane polyether (hydrophobic modified polyether urethane) containing at least one type of C8-36 fat chain; (3) Hydroxypropyl guar compound modified with a group having at least one C8-36 fatty chain; (4) Copolymer of vinylpyrrolidone and a hydrophobic monomer having a C8-36 fatty chain; (5) Copolymer of amphipathic monomer containing C 1-6 alkyl methacrylate or C 1-6 alkyl acrylate and at least one C 8-36 fatty chain; (6) A copolymer of a hydrophobic monomer containing hydrophilic methacrylate or acrylate and at least one C8-36 fatty chain.
  • hydrophobized modified alkyl cellulose examples include those described in WO2011 / 162421, formula (1) :.
  • R 1 , R 2 and R 3 are the same or different, hydrogen atom, alkyl,-[CH 2 CH 2-k (CH 3 ) k O] m -H, or -CH 2 CH (OH). ) CH 2 OC j H 2j + 1 . However, -CH 2 CH (OH) CH 2 OC j H 2j + 1 is always included.
  • n is an integer of 100 to 10000.
  • k is 0 or 1.
  • m is an integer from 1 to 10.
  • j is an integer of 6 to 26.
  • the hydrophobized modified alkyl cellulose is preferably Alkyl is 10 to 50% by mass, -[CH 2 CH 2-k (CH 3 ) k O] m -H is contained in an amount of 3 to 20% by mass, and -CH 2 CH (OH) CH 2 OC j H 2j + 1 is contained in an amount of 0.1 to 10% by mass. ..
  • the hydrophobized modified alkyl cellulose is more preferably one in which j is 18.
  • hydroxypropylmethyl cellulose stearoxy ether for example, Sangelose (registered trademark) (manufactured by Daido Kasei Kogyo Co., Ltd.)
  • Sangelose registered trademark
  • hydrophobically modified polyether urethane examples include those described in WO2018 / 088312, and the formula (2): R 1 - ⁇ (OR 2 ) k -OCONH-R 3 [-NHCOO- (R 4 -O) n -R 5 ] h ⁇ m
  • R 1 , R 2 and R 4 are each independently a hydrocarbon group having 2 to 4 carbon atoms.
  • R 3 is a hydrocarbon group having 1 to 10 carbon atoms which may have a urethane bond.
  • R5 is a hydrocarbon group having 8 to 36 carbon atoms.
  • m is a number of 2 or more.
  • h is a number of 1 or more.
  • k is a number from 1 to 500.
  • n is a number from 1 to 200.
  • hydrophobically modified polyether urethane a (PEG-240 / decyltetradeceth-20 / hexamethyldiisocyanate) copolymer (for example, Adecanol (registered trademark) GT-700 (manufactured by ADEKA)) or the like can be used.
  • a (PEG-240 / decyltetradeceth-20 / hexamethyldiisocyanate) copolymer for example, Adecanol (registered trademark) GT-700 (manufactured by ADEKA)
  • Adecanol registered trademark
  • GT-700 manufactured by ADEKA
  • the associative thickener examples include (a) a nonionic amphoteric polymer, more preferably a hydrophobic modified alkyl cellulose, a hydrophobic modified polyether urethane, and the like, and further preferably hydroxypropylmethyl cellulose steer.
  • a nonionic amphoteric polymer more preferably a hydrophobic modified alkyl cellulose, a hydrophobic modified polyether urethane, and the like, and further preferably hydroxypropylmethyl cellulose steer.
  • examples thereof include rhoxyethers, (PEG-240 / decyltetradeceth-20 / hexamethyldiisocyanate) polymers, and even more preferably hydroxypropylmethylcellulose stearoxy ethers.
  • the mass ratio of (B) anionic polymer compound thickener to (C) associative thickener is It is 5: 1 to 0.15: 1.
  • the mass ratio is preferably 4: 1 to 1: 1 and more preferably 3.5: 1 to 1.2: 1.
  • the gel-like composition of the present invention can contain 5% by mass or more and 20% by mass or less of oil in terms of enhancing the effect of improving skin compatibility.
  • the oil content used in the gel-like composition of the present invention is not particularly limited as long as it is an oil-soluble raw material that can be used in cosmetics and the like.
  • the gel-like composition of the present invention contains water as a solvent. Further, the gel-like composition of the present invention can contain, as other components, components generally blended in cosmetics and the like in an amount suitable for the purpose. Other components include, for example, surfactants (anionic surfactants, nonionic surfactants, cationic surfactants, amphoteric surfactants), moisturizers, functional ingredients, natural product extracts, protein hydrolysis.
  • Substances amino acids, cationized polysaccharides, higher alcohols, polyhydric alcohols, amphoteric polymer resin compounds, cationic polymer resin compounds, preservatives, antioxidants, metal sequestering agents, UV absorbers, UV reflectors, pH adjustment Examples include agents, fragrances and pigments.
  • anionic surfactant examples include alkylbenzene sulfonates, polyoxyalkylene alkyl ether sulfate esters, alkyl sulfate ester salts, olefin sulfonates, dialkyl sulfosuccinates and the like.
  • nonionic surfactant examples include polyoxyethylene fatty acid ester, polyoxyethylene hydrogenated castor oil derivative and the like.
  • the cationic surfactant examples include alkyltrimethylammonium salt, dialkyldimethylammonium salt, alkylpyridinium salt, stearyltrimethylammonium chloride and the like.
  • amphoteric tenside examples include alkyl betaine, alkylamide propyl betaine, imidazolinium betaine, egg yolk lecithin, soybean lecithin and the like.
  • moisturizer examples include diphytosteryl octyldodecyl lauroyl glutamate, phytoglycogen, hydrolyzed eggshell membrane, trehalose, atelocollagen, sorbitol, maltitol and the like.
  • Examples of the functional component include albutin, polyquaternium 51, elastin, platinum nanocolloid, allantin, sodium dilauroyl glutamate lysine, ascorbic magnesium phosphate, L-ascorbic acid 2-glucoside, ellagic acid, niacin, vitamin A oil, and the like.
  • Natural product extracts include, for example, Kujin extract, Kazil extract, Seaweed extract, Eucalyptus extract, Royal jelly extract, Rosemary extract, Beech tree extract, Asenyaku extract, Bunanome extract, Ukon extract, Dokudami extract, Oubaku extract, Merilot extract, Odorikosou extract.
  • Kanzo extract, Shakuyaku extract, Sabonsou extract, Hechima extract, Kina extract, Yukinoshita extract, Clara extract, Kohone extract, Uikyo extract, Sakurasou extract, Rose extract, Dio extract, Lemon extract, Shikon extract, Aloe extract, Shobu root extract, Eucalyptus extract, Sugina extract, sage extract, thyme extract, tea extract, cucumber extract, butterfly extract, strawberry extract, melissa extract, carrot extract, carrot extract, marronnier extract, peach extract, peach leaf extract, kuwa extract, yagurumagiku extract, hamamelis extract, placenta extract, Chest line extract, silk extract and the like can be mentioned.
  • Examples of the protein hydrolyzate include keratin peptide, collagen peptide, soybean peptide, wheat peptide, milk peptide, silk peptide, egg white peptide, hydrolyzed eggshell membrane and the like.
  • Examples of amino acids include arginine, glutamic acid, glycine, alanine, hydroxyproline, cysteine, serine, L-theanine and the like.
  • Examples of the cationized polysaccharide include cationized hydroxyethyl cellulose, cationized guar gum, cationized starch, cationized locust bean gum, cationized dextran, cationized chitosan, cationized honey and the like.
  • Examples of the higher alcohol include cetyl alcohol, behenyl alcohol, isostearyl alcohol, bacillic alcohol and the like.
  • Examples of the polyhydric alcohol include propylene glycol, polyethylene glycol, pentylene glycol, caprylyl glycol, hexanediol, ethylhexyl gluserine, 1,3-butylene glycol, 1,3-propanediol, diglycerin, glycerin and the like. Be done.
  • amphoteric polymer resin compound examples include betaineized dialkylaminoalkyl acrylate copolymers.
  • examples of the cationic polymer resin compound include vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer cationized products, polydimethyldiallyl ammonium halide-type cationic polymers, and the like.
  • examples of the preservative include methylparaben, ethylparaben, butylparaben, propylparaben, phenoxyethanol and the like.
  • examples of the antioxidant include tocopherol, BHT and the like.
  • Examples of the metal sequestering agent include EDTA-2Na, EDTA-4Na, edetate, etidronate and the like.
  • Examples of the ultraviolet absorber include a benzophenone derivative, a para-aminobenzoic acid derivative, a methoxycinnamic acid derivative and the like.
  • Examples of the ultraviolet reflector include titanium oxide, zinc oxide and the like.
  • pH adjuster examples include alkaline hydroxides such as sodium hydroxide and acids such as hydrochloric acid, sulfuric acid, phosphoric acid and methanesulfonic acid.
  • the pH of the gelled composition of the present invention can be adjusted to preferably pH 5 to 7.5, more preferably pH 6 to 7, using a pH adjuster.
  • the gel-like composition of the present invention can be produced according to a conventional method. For example, it can be produced by mixing each of the above components with a thickener and gelling. The produced gel-like composition is filled and sealed in a container or the like according to the intended use.
  • the gel-like composition of the present invention can be suitably used as a high-viscosity cosmetic such as an all-in-one cosmetic and a hair cosmetic.
  • Examples 1 to 16 and Comparative Examples 1 to 4 ⁇ Preparation of gel-like composition> Each component (mass%) shown in Tables 1 to 4 is added to ion-exchanged water (residual) and mixed, and if necessary, an aqueous sodium hydroxide solution is added to adjust the pH to 6 to 7.5. By doing so, the gel-like compositions of Examples 1 to 16 and Comparative Examples 1 to 4 were prepared.
  • Table 5 shows the results of evaluation of the gelled compositions of Examples 1 to 16 and Comparative Examples 1 to 4.
  • the anionic synthetic polymer compound thickener is more preferable in the (B) anionic polymer compound thickener. Further, for example, by comparing Examples 1 to 4, it can be seen that the viscosity increases as the content of the component (B) increases.
  • the gelled compositions of Examples 1 to 6 using the (Acrylate / alkyl acrylate (C10-30)) crosspolymer as the component (B) gave favorable results in the comprehensive evaluation of the feeling of use. .. Therefore, it can be seen that in the (B) anionic polymer compound thickener, an acrylic acid-based anionic polymer compound thickener such as (Acrylate / alkyl acrylate (C10-30)) crosspolymer is more suitable. ..
  • the present invention is in the form of a highly viscous gel containing hyaluronic acid or the like having a high concentration of 0.2% by mass or more, which has stability over time, does not cause non-uniformity of the gel over time, and is less likely to be fooled.
  • the composition is provided.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention pertains to a gel composition that contains 0.2 mass% or more of hyaluronic acid and/or a hyaluronic acid derivative or a salt thereof (A) and that has a viscosity of 15,000-60,000 mPa·s, said gel composition containing 0.1 mass% or more of an anionic polymer compound thickener (B) and 0.05 mass% or more of an associative thickener (C), wherein: the anionic polymer compound thickener (B) is an anionic polymer compound thickener other than the hyaluronic acid and/or a hyaluronic acid derivative or a salt thereof (A); and the ratio by mass of the anionic polymer compound thickener (B) to the associative thickener (C) is 5:1 - 0.15:1.

Description

ゲル状組成物Gel-like composition
 本発明は、ゲル状組成物に関する。 The present invention relates to a gel-like composition.
 ヒアルロン酸は、1934年にMeyerらによって牛の硝子体から分離及び同定された、N-アセチルグルコサミンとD-グルクロン酸が交互に結合した分子量数万~数百万の直鎖状の高分子多糖であり、生体内に広く分布し、皮膚、関節液、血管、脳、軟骨などの結合組織及び器官に存在する。ヒアルロン酸は、保水性が高く、その水分保持能力によって粘性を有し、細胞保持機能を発揮し、組織の柔軟性を保つ働きをする。この特性を利用して、ヒアルロン酸及びヒアルロン酸誘導体が、医薬品、化粧品、食品の原料として幅広く用いられている。例えば、ヒアルロン酸を配合した化粧品は、皮膚表面に水分を含んだ膜を形成し、皮膚の水分蒸散を防ぐ効果があり、肌の保湿状態を保つのに有用である。 Hyaluronic acid is a linear high molecular weight polysaccharide with a molecular weight of tens of thousands to millions, in which N-acetylglucosamine and D-glucuronic acid are alternately bound, which was isolated and identified from bovine vitreous by Meyer et al. In 1934. It is widely distributed in the living body and is present in connective tissues and organs such as skin, joint fluid, blood vessels, brain and cartilage. Hyaluronic acid has high water retention, is viscous due to its water retention capacity, exerts a cell retention function, and functions to maintain the flexibility of tissues. Utilizing this property, hyaluronic acid and hyaluronic acid derivatives are widely used as raw materials for pharmaceuticals, cosmetics, and foods. For example, cosmetics containing hyaluronic acid form a film containing water on the surface of the skin, have the effect of preventing the evaporation of water from the skin, and are useful for maintaining the moisturized state of the skin.
 基礎化粧料として、化粧水、乳液、美容液、クリーム等が存在する。近年、これらの基礎化粧料が一つの化粧料で賄えるオールインワン化粧料が、女性の社会進出と共に、短時間で化粧を行うことができることから、注目を集めている。 There are lotions, milky lotions, beauty essences, creams, etc. as basic cosmetics. In recent years, all-in-one makeup, which can cover these basic makeup with one cosmetic, has been attracting attention because it can be applied in a short time with the advancement of women into society.
 以上の背景から、オールインワン化粧料としても用いることができ、ヒアルロン酸の特性をより積極的に利用した、0.2質量%以上の高濃度のヒアルロン酸等を含有する高粘度のゲル状組成物が望まれている。しかし、高濃度のヒアルロン酸等を含有する高粘度のゲル状組成物は、経時的な安定性が悪く、経時的にゲルの不均一化が生じ、だまになり易いとの問題があった。 From the above background, a highly viscous gel-like composition containing hyaluronic acid or the like having a high concentration of 0.2% by mass or more, which can be used as an all-in-one cosmetic and more positively utilizes the characteristics of hyaluronic acid. Is desired. However, the high-viscosity gel-like composition containing a high concentration of hyaluronic acid and the like has a problem that the stability over time is poor, the gel becomes non-uniform over time, and it is easy to be fooled.
 特許文献1には、増粘剤を0.01質量%以上5質量%以下含有し、増粘剤1部に対してカルボキシメチル基含有修飾ヒアルロン酸及び/又はその塩を0.1部以上5部以下含有するゲル状化粧料が記載されている。しかし、このゲル状化粧料には、高濃度のヒアルロン酸等が含まれているため、経時的な安定性等が十分ではなく、上記問題があった。
 特許文献2及び3には、会合性増粘剤を用いた、ヒアルロン酸等を含有するゲル状組成物が記載されている。しかし、そのゲル状組成物中のヒアルロン酸等の含有量は、多くても0.02質量%及び0.03質量%であり、非常に低濃度である。
 また、特許文献1~3には、増粘剤としてアニオン性高分子化合物増粘剤と会合性増粘剤を組み合わせて用いることは記載されておらず、これらを組み合わせて用いた実施例は存在しない。
Patent Document 1 contains 0.01% by mass or more and 5% by mass or less of a thickener, and 0.1 parts or more and 5 parts or more of modified hyaluronic acid containing a carboxymethyl group and / or a salt thereof with respect to 1 part of the thickener. The gel-like cosmetics containing less than a portion are described. However, since this gel-like cosmetic contains a high concentration of hyaluronic acid and the like, its stability over time is not sufficient, and there is the above problem.
Patent Documents 2 and 3 describe gel-like compositions containing hyaluronic acid and the like, using an associative thickener. However, the content of hyaluronic acid and the like in the gel-like composition is at most 0.02% by mass and 0.03% by mass, which are very low concentrations.
Further, Patent Documents 1 to 3 do not describe the use of an anionic polymer compound thickener and an associative thickener in combination as a thickener, and there are examples in which these are used in combination. do not do.
特開2016-199516号公報Japanese Unexamined Patent Publication No. 2016-199516 特開2018-087148号公報Japanese Unexamined Patent Publication No. 2018-08714 特開2017-036217号公報Japanese Unexamined Patent Publication No. 2017-036217
 本発明の課題は、経時的な安定性を有し、経時的にゲルの不均一化がなく、だまになりにくく、使用感に優れた、0.2質量%以上の高濃度のヒアルロン酸等を含有する高粘度のゲル状組成物を提供することにある。 The subject of the present invention is hyaluronic acid having a high concentration of 0.2% by mass or more, which has stability over time, does not have gel inhomogeneity over time, is less likely to be fooled, and has an excellent usability. It is an object of the present invention to provide a highly viscous gel-like composition containing.
 本発明者らは、上記本発明の課題を解決するべく、様々な増粘剤を用いて鋭意検討した結果、増粘剤として、(B)アニオン性高分子化合物増粘剤のみを用いた場合、及び(C)会合性増粘剤のみを用いた場合は、得られた高濃度のヒアルロン酸等を含有するゲル状組成物は経時的な安定性が無かったが、(B)アニオン性高分子化合物増粘剤と(C)会合性増粘剤とを5:1~0.15:1の質量比で組み合わせたところ、0.2質量%以上の高濃度のヒアルロン酸等を含有する高粘度のゲル状組成物が、意外にも経時的な安定性を有し、経時的にゲルの不均一化がなく、だまになりにくいことを見出して、本発明を完成した。 As a result of diligent studies using various thickeners in order to solve the above-mentioned problems of the present invention, the present inventors have made a case where only (B) anionic polymer compound thickener is used as the thickener. And (C) When only the associative thickener was used, the obtained gel-like composition containing a high concentration of hyaluronic acid and the like was not stable over time, but (B) was highly anionic. When the molecular compound thickener and the (C) associative thickener are combined in a mass ratio of 5: 1 to 0.15: 1, a high concentration of 0.2% by mass or more of hyaluronic acid or the like is contained. The present invention has been completed by finding that the gel-like composition having a viscosity unexpectedly has stability over time, does not cause non-uniformity of the gel over time, and is less likely to be fooled.
 すなわち、本発明は、以下の通りである。
 [1](A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩を0.2質量%以上含有し、粘度が15000~60000mPa・sであるゲル状組成物であって、
 ゲル状組成物は、(B)アニオン性高分子化合物増粘剤を0.1質量%以上、(C)会合性増粘剤を0.05質量%以上含有し、
 (B)アニオン性高分子化合物増粘剤は、(A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩以外のアニオン性高分子化合物増粘剤であり、
 (B)アニオン性高分子化合物増粘剤と(C)会合性増粘剤の質量比が、5:1~0.15:1である、ゲル状組成物。
That is, the present invention is as follows.
[1] (A) A gel-like composition containing 0.2% by mass or more of hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof and having a viscosity of 15,000 to 60,000 mPa · s.
The gel-like composition contains (B) anionic polymer compound thickener in an amount of 0.1% by mass or more and (C) an associative thickener in an amount of 0.05% by mass or more.
The (B) anionic polymer compound thickener is an anionic polymer compound thickener other than (A) hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof.
A gel-like composition in which the mass ratio of the (B) anionic polymer compound thickener to the (C) associative thickener is 5: 1 to 0.15: 1.
 [2](C)会合性増粘剤が疎水化変性アルキルセルロースである、[1]に記載のゲル状組成物。
 [3](A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩から選択される少なくとも1つのうち、平均分子量が50万~200万であるものを0.1質量%以上含有する、[1]又は[2]に記載のゲル状組成物。
 [4] (A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩からなる群から選択される1つ以上のうち、平均分子量が50万~200万であるものを0.1質量%以上含有し、平均分子量が1万以下であるものを0.1質量%以上含有する、[1]又は[2]に記載のゲル状組成物。
 [5]粘度が25000~45000mPa・sである、[1]~[4]のいずれかに記載のゲル状組成物。
[2] The gel-like composition according to [1], wherein the (C) associative thickener is hydrophobized modified alkyl cellulose.
[3] (A) At least one selected from hyaluronic acid and / or hyaluronic acid derivatives or salts thereof, containing 0.1% by mass or more having an average molecular weight of 500,000 to 2,000,000 [1]. ] Or the gel-like composition according to [2].
[4] (A) Among one or more selected from the group consisting of hyaluronic acid and / or hyaluronic acid derivatives or salts thereof, those having an average molecular weight of 500,000 to 2 million are contained in an amount of 0.1% by mass or more. The gelled composition according to [1] or [2], which contains 0.1% by mass or more of an average molecular weight of 10,000 or less.
[5] The gel-like composition according to any one of [1] to [4], which has a viscosity of 25,000 to 45,000 mPa · s.
 本発明のゲル状組成物は、経時的な安定性を有し、経時的にゲルの不均一化がなく、だまになりにくく、肌へののびが良く、べとつきが無く、使用感に優れている。 The gel-like composition of the present invention has stability over time, does not have gel non-uniformity over time, is less likely to be fooled, spreads well on the skin, is not sticky, and is excellent in usability. There is.
1.ゲル状組成物
 本発明は、(A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩を0.2質量%以上含有し、粘度が15000~60000mPa・sであるゲル状組成物であって、ゲル状組成物は、(B)アニオン性高分子化合物増粘剤を0.1質量%以上、(C)会合性増粘剤を0.05質量%以上含有し、(B)アニオン性高分子化合物増粘剤と(C)会合性増粘剤の質量比が、5:1~0.15:1である、ゲル状組成物に関する。
1. 1. Gel-like composition The present invention is a gel-like composition containing (A) hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof in an amount of 0.2% by mass or more and having a viscosity of 15,000 to 60,000 mPa · s. The gel-like composition contains (B) an anionic polymer compound thickener in an amount of 0.1% by mass or more, (C) an associative thickener in an amount of 0.05% by mass or more, and (B) an anionic polymer. The present invention relates to a gel-like composition in which the mass ratio of the compound thickener to the (C) associative thickener is 5: 1 to 0.15: 1.
<(A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩>
 ヒアルロン酸としては、動物組織から抽出したものや微生物の培養による発酵法で生産されたもの等が知られ、市販のヒアルロン酸を適宜用いればよく、例えば、平均分子量が50万~300万であるもの、更に高分子量のもの、平均分子量が1万以下の低分子化されたもの等を用いることができる。低分子のヒアルロン酸は、例えば高分子のヒアルロン酸を緩衝液に溶解後、ヒアルロニダーゼを加えて数日間インキュベートし、酵素を失活させた後、生成する方法(特開平10-195107)、高分子のヒアルロン酸を酸等で加水分解する方法等を用いて製造される。本発明で規定されるヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩の平均分子量は、以下の方法により測定することができる。
<(A) Hyaluronic acid and / or hyaluronic acid derivative or salt thereof>
As the hyaluronic acid, those extracted from animal tissues, those produced by a fermentation method by culturing microorganisms, and the like are known, and commercially available hyaluronic acid may be appropriately used. For example, the average molecular weight is 500,000 to 3,000,000. Those having a high molecular weight, those having a high molecular weight, those having an average molecular weight of 10,000 or less, and the like can be used. Low-molecular-weight hyaluronic acid is produced, for example, by dissolving high-molecular-weight hyaluronic acid in a buffer solution, adding hyaluronidase, incubating for several days, inactivating the enzyme, and then producing (Japanese Patent Laid-Open No. 10-195107). It is produced by using a method of hydrolyzing hyaluronic acid with an acid or the like. The average molecular weight of hyaluronic acid and / or hyaluronic acid derivatives or salts thereof specified in the present invention can be measured by the following method.
 まず、ゲル濾過カラムを用いて、分子量が既知である複数のヒアルロン酸(基準物質)を液体クロマトグラフィー分析することで、それらの保持時間より検量線を作成する。同様に、測定対象であるヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩を液体クロマトグラフィー分析し、上記検量線を用いて分子量を求めることで、ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩の分子量を求めることができる。
 液体クロマトグラフィー分析に使用することができる液体クロマトグラフィー分析装置としては、例えば、Waters Alliance 2690 HPLC Separations Module(Waters社製)、Waters Alliance 2695 HPLC Separations Module(Waters社製)、1200 Series(Agilent社製)が挙げられる。また、液体クロマトグラフィー分析に使用することができるカラムとしては、例えば、shodex社製配位子交換クロマトグラフィー用カラム(配位子交換モード+サイズ排除モード)、型名「SUGAR KS-801」、「SUGAR KS-802」、「SUGAR KS-803」、「SUGAR KS-804」、「SUGAR KS-805」、「SUGAR KS-806」、「SUGARKS-807」や、TOSOH製サイズ排除クロマトグラフィーカラム、型名「TSKgel GMPW」が挙げられる。
First, a calibration curve is prepared from the retention time of a plurality of hyaluronic acids (reference substances) having known molecular weights by liquid chromatography analysis using a gel filtration column. Similarly, hyaluronic acid and / or hyaluronic acid derivatives or salts thereof to be measured are analyzed by liquid chromatography and the molecular weight is determined using the above calibration curve to obtain hyaluronic acid and / or hyaluronic acid derivatives or salts thereof. The molecular weight of can be determined.
Examples of the liquid chromatography analyzer that can be used for liquid chromatography analysis include Waters Alliance 2690 HPLC Separations Module (Waters), Waters Alliance 2695 HPLC Separations Module (Waters), 1200 Agilents. ). Examples of the column that can be used for liquid chromatography analysis include a column for ligand exchange chromatography manufactured by shodex (ligand exchange mode + size exclusion mode), model name "SUGAR KS-801", and the like. "SUGAR KS-802", "SUGAR KS-803", "SUGAR KS-804", "SUGAR KS-805", "SUGAR KS-806", "SUGAR KS-807", and TOSOH size exclusion chromatography columns, The model name "TSKgel GMPW" can be mentioned.
 ヒアルロン酸誘導体としては、ヒアルロン酸のヒドロキシル基、カルボキシル基等がエーテル化、エステル化、アセチル化、アミド化、アセタール化、ケタール化されて得られる誘導体等が挙げられる。具体的には、例えば、第四級アンモニウム基含有基を有するカチオン化ヒアルロン酸(WO2008/133267)、グリセリン骨格含有基を含む修飾ヒアルロン酸(WO2011/102462)、カルボキシメチル基含有修飾ヒアルロン酸(WO2016/159159、特開2015-147945)、ヒドロキシ基の一部が第4級窒素含有基で置換された低分子量カチオン化ヒアルロン酸(特開2016-108344)等が挙げられる。
 ヒアルロン酸及びヒアルロン酸誘導体は、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩、塩基性アミノ酸塩、亜鉛塩等の塩であってもよい。
Examples of the hyaluronic acid derivative include derivatives obtained by etherifying, esterifying, acetylating, amidating, acetalizing, and ketalizing the hydroxyl group and carboxyl group of hyaluronic acid. Specifically, for example, a cationized hyaluronic acid having a quaternary ammonium group-containing group (WO2008 / 133267), a modified hyaluronic acid containing a glycerin skeleton-containing group (WO2011 / 102462), and a carboxymethyl group-containing modified hyaluronic acid (WO2016). / 159159 (Japanese Patent Laid-Open No. 2015-147945), low molecular weight cationized hyaluronic acid in which a part of the hydroxy group is replaced with a quaternary nitrogen-containing group (Japanese Patent Laid-Open No. 2016-108344) and the like can be mentioned.
The hyaluronic acid and the hyaluronic acid derivative may be salts such as sodium salt, potassium salt, calcium salt, magnesium salt, ammonium salt, basic amino acid salt and zinc salt.
 ヒアルロン酸及び/又はヒアルロン酸誘導体としては、市販のヒアルロン酸及び/又はヒアルロン酸誘導体を適宜用いればよい。高濃度のヒアルロン酸等を含有するゲル状組成物でも、経時的な安定性が得られることから、ヒアルロン酸及び/又はヒアルロン酸誘導体としては、平均分子量が50万以上200万以下のヒアルロン酸又はヒアルロン酸誘導体を1種以上と平均分子量1万以下のヒアルロン酸又はヒアルロン酸誘導体を1種以上の、少なくとも2種以上のヒアルロン酸及び/又はヒアルロン酸誘導体を組み合わせることが好ましい。ヒアルロン酸及び/又はヒアルロン酸誘導体としては、平均分子量が50万以上200万以下のヒアルロン酸及び/又はヒアルロン酸誘導体を2種以上と平均分子量1万以下のヒアルロン酸及び/又はヒアルロン酸誘導体を2種以上の、少なくとも4種以上のヒアルロン酸及び/又はヒアルロン酸誘導体を組み合わせることが更に好ましい。
 また、ヒアルロン酸及び/又はヒアルロン酸誘導体としては、平均分子量50万以上200万以下の中高分子ヒアルロン酸、平均分子量1万以下の低分子ヒアルロン酸及び/又はヒアルロン酸誘導体、第四級アンモニウム基含有基を有する平均分子量50万以上200万以下のカチオン化ヒアルロン酸誘導体、平均分子量50万以上200万以下のカルボキシメチル基を含むヒアルロン酸誘導体、グリセリン骨格含有基を含む修飾ヒアルロン酸、ヒアルロン酸亜鉛等が挙げられ、これらを組み合わせたものも好ましい(特開2016-166133)。
 平均分子量50万以上200万以下のヒアルロン酸及び/又はヒアルロン酸誘導体は、皮膚表面に留まり、皮膚表面から水分が蒸発することを防ぐ性質を有するため、持続的な皮膚の保湿効果を発揮する。
As the hyaluronic acid and / or the hyaluronic acid derivative, a commercially available hyaluronic acid and / or the hyaluronic acid derivative may be appropriately used. Since a gel-like composition containing a high concentration of hyaluronic acid or the like can be stabilized over time, the hyaluronic acid and / or the hyaluronic acid derivative has an average molecular weight of 500,000 or more and 2 million or less. It is preferable to combine one or more hyaluronic acid derivatives and one or more hyaluronic acid or hyaluronic acid derivatives having an average molecular weight of 10,000 or less, and at least two or more types of hyaluronic acid and / or hyaluronic acid derivatives. The hyaluronic acid and / or the hyaluronic acid derivative includes two or more hyaluronic acid and / or hyaluronic acid derivatives having an average molecular weight of 500,000 or more and 2 million or less, and hyaluronic acid and / or hyaluronic acid derivatives having an average molecular weight of 10,000 or less. It is more preferable to combine at least 4 kinds of hyaluronic acid and / or hyaluronic acid derivatives of more than one kind.
The hyaluronic acid and / or hyaluronic acid derivative contains a medium-high molecular weight hyaluronic acid having an average molecular weight of 500,000 or more and 2 million or less, a low-molecular-weight hyaluronic acid having an average molecular weight of 10,000 or less, and / or a hyaluronic acid derivative, and a quaternary ammonium group. Catified hyaluronic acid derivative having an average molecular weight of 500,000 or more and 2 million or less, hyaluronic acid derivative containing a carboxymethyl group having an average molecular weight of 500,000 or more and 2 million or less, modified hyaluronic acid containing a glycerin skeleton-containing group, zinc hyaluronate, etc. However, a combination thereof is also preferable (Japanese Patent Laid-Open No. 2016-166133).
Hyaluronic acid and / or hyaluronic acid derivatives having an average molecular weight of 500,000 or more and 2 million or less have a property of staying on the skin surface and preventing water from evaporating from the skin surface, and thus exhibit a continuous skin moisturizing effect.
 平均分子量1万以下の低分子ヒアルロン酸及び/又はヒアルロン酸誘導体は、より好ましくは800以上1万以下、1,000以上1万以下である平均分子量のものが挙げられる。この低分子ヒアルロン酸及び/又はヒアルロン酸誘導体は、皮膚への浸透性が高く、角質層の潤いを向上させる性質を有するため、持続的な皮膚の保湿効果を発揮する。
 第四級アンモニウム基含有基を有するカチオン化ヒアルロン酸誘導体は、より好ましくはカチオン化度が0.15~0.6であるもの、更に好ましくはカチオン化度が0.15~0.4であるものが挙げられる。カチオン化度とは、ヒアルロン酸の構成単位である二糖当たりの第四級アンモニウム基含有基の数をいい、常法により、セミミクロケルダール法により求められる。このカチオン化ヒアルロン酸は、持続的な皮膚の保湿効果を発揮する。
Examples of the low molecular weight hyaluronic acid and / or hyaluronic acid derivative having an average molecular weight of 10,000 or less include those having an average molecular weight of 800 or more and 10,000 or less and 1,000 or more and 10,000 or less. This low-molecular-weight hyaluronic acid and / or hyaluronic acid derivative has a high permeability to the skin and has a property of improving the moisturization of the stratum corneum, and thus exhibits a continuous skin moisturizing effect.
The cationized hyaluronic acid derivative having a quaternary ammonium group-containing group more preferably has a cationization degree of 0.15 to 0.6, and more preferably has a cationization degree of 0.15 to 0.4. Things can be mentioned. The degree of cationization refers to the number of quaternary ammonium group-containing groups per disaccharide, which is a constituent unit of hyaluronic acid, and is determined by a conventional method or a semi-micro Kjeldahl method. This cationized hyaluronic acid exerts a long-lasting moisturizing effect on the skin.
 カルボキシメチル基を含む修飾ヒアルロン酸誘導体の、「カルボキシメチル基」とは、「-CH-COH」または「-CH-CO 」で表される基のことをいい、少なくとも一部にカルボキシメチル基が導入されているヒアルロン酸のことをいう。カルボキシメチル基を含む修飾ヒアルロン酸誘導体は、より好ましくはヒアルロン酸を構成する2糖単位に対するカルボキシメチル化率が5%以上200%以下であるもの、更に好ましくはヒアルロン酸を構成する2糖単位に対するカルボキシメチル化率が60%以上200%以下であるものが挙げられる。 The "carboxymethyl group" of the modified hyaluronic acid derivative containing a carboxymethyl group means a group represented by "-CH 2 - CO 2 H" or "-CH 2 -CO 2- ", and at least one. Hyaluronic acid in which a carboxymethyl group is introduced. The modified hyaluronic acid derivative containing a carboxymethyl group more preferably has a carboxymethylation rate of 5% or more and 200% or less with respect to the disaccharide unit constituting hyaluronic acid, and more preferably with respect to the disaccharide unit constituting hyaluronic acid. Examples thereof include those having a carboxymethylation rate of 60% or more and 200% or less.
 ヒアルロン酸を構成する2糖単位とは、ヒアルロン酸を構成する、隣り合って結合する2糖(グルクロン酸及びN-アセチルグルコサミン)で構成される1単位をいい、ヒアルロン酸を構成する2糖単位に対するカルボキシメチル化率とは、該1単位に対する、該1単位に含まれるカルボキシメチル基の数であり、より具体的には、該1単位を100%とした場合、該1単位に対する、該1単位に含まれるカルボキシメチル基の数の割合(%)をいう。このカルボキシメチル基を含む修飾ヒアルロン酸誘導体は、持続的な皮膚の保湿効果を発揮する。 The disaccharide unit constituting hyaluronic acid refers to one unit composed of adjacently bonded disaccharides (glucuronic acid and N-acetylglucosamine) constituting hyaluronic acid, and is a disaccharide unit constituting hyaluronic acid. The carboxymethylation rate with respect to 1 unit is the number of carboxymethyl groups contained in the 1 unit, and more specifically, when the 1 unit is 100%, the 1 unit is related to the 1 unit. The ratio (%) of the number of carboxymethyl groups contained in the unit. This modified hyaluronic acid derivative containing a carboxymethyl group exerts a long-lasting moisturizing effect on the skin.
 グリセリン骨格含有基を含む修飾ヒアルロン酸は、好ましくは式:-O-CH-CHOH-CH-OR(式中、Rは直鎖状若しくは分岐状のアルキル又はアルケニルを表す。)で表されるグリセリン骨格含有基を含む修飾ヒアルロン酸である。この修飾ヒアルロン酸は、水層及び脂質層からなるラメラ構造を修復し、皮膚のバリア機能修復効果を改善する性質を有するため、持続的な皮膚の保湿効果を発揮する。
 ヒアルロン酸亜鉛は、ヒアルロン酸を構成するカルボキシル基に由来するカルボキシルイオンと亜鉛イオンとの相互作用により形成される複合体である。好ましいヒアルロン酸亜鉛は、1g当たりの亜鉛含有量が55~100mgであるもの、より好ましくは60~80mgであるものが挙げられる。ヒアルロン酸亜鉛は、持続的な皮膚の保湿効果を発揮する。
The modified hyaluronic acid containing a glycerin skeleton-containing group is preferably of the formula: -O-CH 2 -CHOH-CH 2 -OR 1 (where R 1 represents a linear or branched alkyl or alkenyl). It is a modified hyaluronic acid containing a glycerin skeleton-containing group represented. This modified hyaluronic acid has the property of repairing the lamellar structure composed of the aqueous layer and the lipid layer and improving the barrier function repairing effect of the skin, and thus exerts a continuous skin moisturizing effect.
Zinc hyaluronic acid is a complex formed by the interaction of zinc ions with carboxyl ions derived from the carboxyl groups constituting hyaluronic acid. Preferred zinc hyaluronates have a zinc content of 55 to 100 mg per gram, more preferably 60 to 80 mg. Zinc hyaluronate exerts a long-lasting moisturizing effect on the skin.
 本発明のゲル状組成物中に、0.2質量%以上のヒアルロン酸及び/又はヒアルロン酸誘導体が含有される。好ましい含有量としては、0.2~5質量%が挙げられ、より好ましくは、0.25~3質量%が挙げられ、更に好ましくは0.3~2質量%が挙げられる。
 本発明のゲル状組成物中に、5質量%以上のヒアルロン酸及び/又はヒアルロン酸誘導体を含有すると、ゲル状組成物の粘度が高くなり、経時的な安定性が不十分となり、経時的にゲルの不均一化が生じることがある。
The gel-like composition of the present invention contains 0.2% by mass or more of hyaluronic acid and / or a hyaluronic acid derivative. Preferred contents include 0.2 to 5% by mass, more preferably 0.25 to 3% by mass, and further preferably 0.3 to 2% by mass.
When 5% by mass or more of hyaluronic acid and / or a hyaluronic acid derivative is contained in the gel-like composition of the present invention, the viscosity of the gel-like composition becomes high, the stability over time becomes insufficient, and over time. Gel non-uniformity may occur.
 また、ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩からなる群から選択される1つ以上のうち、平均分子量が50万~200万であるものを0.1質量%以上含有することが好ましい。0.1質量%以上含有することで、皮膚表面に留まり、皮膚表面から水分が蒸発することを防ぐ性質を有するため、持続的な皮膚の保湿効果が発揮される。より好ましい含有量としては、0.1~3質量%が挙げられ、更に好ましくは、0.1~1質量%が挙げられ、更により好ましくは0.1~0.2質量%が挙げられる。
 また、アルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩からなる群から選択される1つ以上のうち、平均分子量が1万以下であるものを0.1質量%以上含有することが好ましい。0.1質量%以上含有することで、皮膚への浸透性が高く、角質層の潤いを向上させる性質を有するため、持続的な皮膚の保湿効果を発揮される。より好ましい含有量としては、0.1~3質量%以上が挙げられ、更に好ましくは、0.1~1質量%が挙げられ、更により好ましくは0.1~0.25質量%が挙げられる。
Further, among one or more selected from the group consisting of hyaluronic acid and / or hyaluronic acid derivatives or salts thereof, those having an average molecular weight of 500,000 to 2,000,000 are preferably contained in an amount of 0.1% by mass or more. .. When it is contained in an amount of 0.1% by mass or more, it stays on the skin surface and has a property of preventing water from evaporating from the skin surface, so that a continuous skin moisturizing effect is exhibited. The more preferable content is 0.1 to 3% by mass, more preferably 0.1 to 1% by mass, and even more preferably 0.1 to 0.2% by mass.
Further, among one or more selected from the group consisting of aluronic acid and / or hyaluronic acid derivatives or salts thereof, those having an average molecular weight of 10,000 or less are preferably contained in an amount of 0.1% by mass or more. When it is contained in an amount of 0.1% by mass or more, it has a high permeability to the skin and has a property of improving the moisturization of the stratum corneum, so that a continuous skin moisturizing effect is exhibited. More preferable content is 0.1 to 3% by mass or more, further preferably 0.1 to 1% by mass, and even more preferably 0.1 to 0.25% by mass. ..
<(B)アニオン性高分子化合物増粘剤>
 アニオン性高分子化合物増粘剤は、(A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩以外のアニオン性高分子化合物増粘剤であり、例えば、カルボキシ基、スルホ基、ホスホ基等から選択されるアニオン性基を分子内に有する高分子化合物であり、合成高分子であってもよく、天然高分子であってもよい。好ましくは、アニオン性高分子化合物増粘剤は、カルボキシ基を分子内に有する。
<(B) Anionic polymer compound thickener>
The anionic polymer compound thickener is an anionic polymer compound thickener other than (A) hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof, and is, for example, from a carboxy group, a sulfo group, a phospho group, or the like. It is a polymer compound having a selected anionic group in the molecule, and may be a synthetic polymer or a natural polymer. Preferably, the anionic polymer compound thickener has a carboxy group in the molecule.
 アニオン性合成高分子化合物増粘剤としては、例えば、不飽和モノカルボン酸系モノマー(アクリル酸、メタクリル酸、クロトン酸、これらの酸の中和物、及び部分中和物等)、不飽和ジカルボン酸系モノマー(マレイン酸、フマル酸、イタコン酸、シトラコン酸、これらの酸の中和物、及び部分中和物等)、及び不飽和スルホン酸系モノマー(ビニルスルホン酸、アリルスルホン酸、メタクリルスルホン酸、スチレンスルホン酸、2-アクリルアミド-2-メチルプロパンスルホン酸、スルホエチル(メタ)アクリレート、スルホエチルマレイミド、3-アリロキシ-2-ヒドロキシプロパンスルホン酸、これら酸の中和物、及び部分中和物等)等から成る群より選択されるモノマーで構成されるホモポリマー、上記モノマーの任意の組み合わせからなる共重合体、上記モノマーと共重合可能な他のモノマーとの共重合体等が挙げられる。具体的には、(アクリレーツ/アクリル酸アルキル(炭素数10~30))クロスポリマー、(アクリル酸/ビニルピロリドン)クロスポリマー、(メチルビニルエーテル/マレイン酸)クロスポリマー、アルキル変性カルボキシビニルポリマー、カルボキシビニルポリマー、アクリル酸アルキル/メタクリル酸ステアレス-20コポリマー、アクリルコポリマー、アクリレーツ/メタクリル酸ステアレス-20コポリマー、アクリレーツ/イタコン酸ステアレス-20コポリマー、ポリアクリル酸、アクリレーツ/メタクリル酸ベヘネス-25コポリマー、アクリレーツ/メタクリル酸ラウレス-25コポリマー、アクリレーツ/ネオデカン酸ビニルクロスコポリマー、アクリル酸アルキル/メタクリル酸ステアレス-20クロスポリマー、アクリレーツ/メタクリル酸ステアレス-20クロスコポリマー、メチルビニルエーテル・無水マレイン酸・デカジエンクロスポリマー、アクリル酸・メタクリル酸アルキル共重合体、ビニルピロリドン/アクリレート/ラウリルメタアクリレートコポリマー、アクリレーツコポリマー、ポリアクリル酸Na、アルギン酸Na、(アクリロイルジメチルタウリンアンモニウム/メタクリル酸ベヘネス-25)クロスポリマー等が挙げられる。 Examples of the anionic synthetic polymer compound thickener include unsaturated monocarboxylic acid-based monomers (acrylic acid, methacrylic acid, clonic acid, neutralized products of these acids, partially neutralized products, etc.) and unsaturated dicarboxylic acids. Acid-based monomers (maleic acid, fumaric acid, itaconic acid, citraconic acid, neutralized products of these acids, partially neutralized products, etc.), and unsaturated sulfonic acid-based monomers (vinyl sulfonic acid, allyl sulfonic acid, methacrylic sulfone, etc.) Acids, styrene sulfonic acids, 2-acrylamide-2-methyl propane sulfonic acids, sulfoethyl (meth) acrylates, sulfoethyl maleimides, 3-allyloxy-2-hydroxypropane sulfonic acids, neutralized and partially neutralized products of these acids. Etc.), homopolymers composed of monomers selected from the group consisting of the above-mentioned monomers, copolymers composed of arbitrary combinations of the above-mentioned monomers, copolymers of the above-mentioned monomers with other monomers commutable, and the like. Specifically, (Acrylate / alkyl acrylate (10 to 30 carbon atoms)) cross polymer, (acrylic acid / vinylpyrrolidone) cross polymer, (methyl vinyl ether / maleic acid) cross polymer, alkyl-modified carboxyvinyl polymer, carboxyvinyl Polymer, Alkyl Acrylic Acid / Steareth Methacrylate-20 Copolymer, Acrylic Copolymer, Acrylate / Steareth Methacrylate-20 Polymer, Acrylate / Steareth Itaconic Acid-20 Polymer, Polyacrylic Acid, Acrylate / Behenes methacrylate-25 Copolymer, Acrylate / Methacrylate Laureth -25 Copolymer, Acrylate / Vinyl Neodecanoate Cross Polymer, Alkyl Acrylic Acid / Steareth Methacrylate-20 Cross Polymer, Acrylate / Steareth Methacrylate-20 Cross Polymer, Methyl Vinyl Ether / Maleic Anhydrous / Decadien Cross Polymer, Acrylic Acid Examples thereof include alkyl methacrylate copolymers, vinylpyrrolidone / acrylate / lauryl methacrylate copolymers, acrylates copolymers, Na polyacrylate, Na alginate, (acryloyldimethyltaurine ammonium / Behenes-25 methacrylate) crosspolymers and the like.
 アニオン性天然高分子化合物増粘剤としては、ペクチン酸、アルギン酸、寒天、カラギーナン、フコイダン、ヘパリン、ジェランガム、ネイティブジェランガム、キサンタンガム、デヒドロキサンタンガム、アラビアゴム、カルボキシメチルセルロース、カルボキシメチルヒドロキシエチルセルロース、カルボキシメチルデンプン、カルボキシメチルデキストラン、ポリグルタミン酸、サクシニル化コラーゲン、カルボキシメチルキチン、サクシニル化キトサン、セルロース硫酸ナトリウム、ゼラチン、ムチン、デキストラン等が挙げられる。 Anionic natural polymer compound thickeners include pectic acid, alginic acid, agar, carrageenan, fucoidan, heparin, gellan gum, native gellan gum, xanthan gum, dextran gum, arabic rubber, carboxymethyl cellulose, carboxymethyl hydroxyethyl cellulose, carboxymethyl starch, Examples thereof include carboxymethyl dextran, polyglutamic acid, succinylated collagen, carboxymethyl chitin, succinylated chitosan, sodium cellulose sulfate, gelatin, mucin, dextran and the like.
 好ましいアニオン性高分子化合物増粘剤として、アニオン性合成高分子化合物増粘剤が挙げられる。より好ましくは、(メタ)アクリル酸・(メタ)アクリル酸アルキル共重合体等のアクリル酸系アニオン性高分子化合物増粘剤が挙げられ、更に好ましくはアクリル酸・メタクリル酸アルキル共重合体が挙げられ、更により好ましくは(アクリレーツ/アクリル酸アルキル(炭素数10~30))クロスポリマーが挙げられる。
 ゲル状組成物中に、0.1質量%以上のアニオン性高分子化合物増粘剤が含有される。好ましい含有量としては、0.1~2質量%が挙げられ、より好ましくは、0.15~1質量%が挙げられ、更に好ましくは0.2~0.5質量%が挙げられる。
Preferred anionic polymer compound thickeners include anionic synthetic polymer compound thickeners. More preferably, an acrylic acid-based anionic polymer compound thickener such as a (meth) acrylic acid / alkyl (meth) acrylic acid copolymer is mentioned, and more preferably, an acrylic acid / alkyl methacrylate copolymer is mentioned. And even more preferably (Acrylate / alkyl acrylate (10 to 30 carbon atoms)) crosspolymers.
The gel-like composition contains 0.1% by mass or more of an anionic polymer compound thickener. Preferred contents include 0.1 to 2% by mass, more preferably 0.15 to 1% by mass, and further preferably 0.2 to 0.5% by mass.
<(C)会合性増粘剤>
 会合性増粘剤は、親水性領域と疎水性領域の両方を含む増粘剤である。例えば、少なくとも1種のC8~36脂肪鎖等を含む疎水性領域と少なくとも1種の親水性領域を有する増粘剤が挙げられる。会合性増粘剤として、例えば、Encyclopedia of Polymer Science and Engineering,第2版,17,772-779に定義されるものが挙げられる。疎水性領域は疎水性部分と結合することができ、親水性領域は親水性部分と結合することができる。会合性増粘剤は、これらの結合によって、すなわち、疎水性領域同士が会合することによって、更には疎水性領域と他の疎水性物質とが会合することによって、ネットワーク(網目構造)を形成し、増粘作用が発現される。
<(C) Associative thickener>
Associative thickeners are thickeners that contain both hydrophilic and hydrophobic areas. For example, a thickener having a hydrophobic region containing at least one C8-36 fat chain and a hydrophilic region and at least one hydrophilic region can be mentioned. Associative thickeners include, for example, those defined in the Encyclopedia of Polymer Science and Engineering, 2nd Edition, 17, 772-779. Hydrophobic regions can bind to hydrophobic moieties and hydrophilic regions can bind to hydrophilic moieties. The associative thickener forms a network (network structure) by these bonds, that is, by associating the hydrophobic regions with each other, and further by associating the hydrophobic regions with other hydrophobic substances. , Thickening action is exhibited.
 会合性増粘剤として、例えば、特表2015-514788、特表2017-31064、特表2016-519159、特表2005-500397、WO2011/162421、WO2018/088312等に記載されたものが挙げられる。
 会合性増粘剤には、以下のものが例示される。
(a)少なくとも1種のC8~36脂肪鎖及び少なくとも1種の親水性単位を含有するノニオン型両親媒性ポリマー;
(b)少なくとも1種の親水性単位及びC8~36脂肪鎖を有する少なくとも1種の単位を含有するアニオン型両親媒性ポリマー;
(c)少なくとも1種の親水性単位及びC8~36脂肪鎖を有する少なくとも1種の単位を含有するカチオン型両親媒性ポリマー;
(d)少なくとも1種の親水性単位及びC8~36脂肪鎖を有する少なくとも1種の単位を含有する両性型両親媒性ポリマー。
Examples of the associative thickener include those described in Special Table 2015-514788, Special Table 2017-310649, Special Table 2016-591159, Special Table 2005-500397, WO2011 / 162421, WO2018 / 088312 and the like.
Examples of associative thickeners include:
(A) Nonionic amphipathic polymer containing at least one C8-36 fatty chain and at least one hydrophilic unit;
(B) An anionic amphipathic polymer containing at least one hydrophilic unit and at least one unit having a C8-36 fatty chain;
(C) A cationic amphipathic polymer containing at least one hydrophilic unit and at least one unit having a C8-36 fatty chain;
(D) An amphoteric amphoteric polymer containing at least one hydrophilic unit and at least one unit having a C8-36 fatty chain.
 これらの会合性増粘剤のうち、(a)ノニオン型両親媒性ポリマーが好ましい。この(a)ノニオン型両親媒性ポリマーとしては、以下のものが例示される。
(1)少なくとも1種のC8~36脂肪鎖を有する基で変性されたセルロース(疎水化変性アルキルセルロース);
(2)少なくとも1種のC8~36脂肪鎖を含有するウレタンポリエーテル(疎水性変性ポリエーテルウレタン);
(3)少なくとも1種のC8~36脂肪鎖を有する基で変性されたヒドロキシプロピルグアー化合物;
(4)ビニルピロリドンとC8~36脂肪鎖を有する疎水性モノマーのコポリマー;
(5)C1~6アルキルメタクリレート又はC1~6アルキルアクリレートと少なくとも1種のC8~36脂肪鎖を含有する両親媒性モノマーのコポリマー;
(6)親水性メタクリレート又はアクリレートと少なくとも1種のC8~36脂肪鎖を含有する疎水性モノマーのコポリマー。
Of these associated thickeners, (a) nonionic amphipathic polymers are preferred. Examples of the (a) nonionic amphipathic polymer include the following.
(1) Cellulose modified with a group having at least one C8-36 fatty chain (hydrophobic modified alkyl cellulose);
(2) Urethane polyether (hydrophobic modified polyether urethane) containing at least one type of C8-36 fat chain;
(3) Hydroxypropyl guar compound modified with a group having at least one C8-36 fatty chain;
(4) Copolymer of vinylpyrrolidone and a hydrophobic monomer having a C8-36 fatty chain;
(5) Copolymer of amphipathic monomer containing C 1-6 alkyl methacrylate or C 1-6 alkyl acrylate and at least one C 8-36 fatty chain;
(6) A copolymer of a hydrophobic monomer containing hydrophilic methacrylate or acrylate and at least one C8-36 fatty chain.
 疎水化変性アルキルセルロースとしては、WO2011/162421に記載されたものが挙げられ、式(1): Examples of the hydrophobized modified alkyl cellulose include those described in WO2011 / 162421, formula (1) :.
Figure JPOXMLDOC01-appb-C000001
〔式中、R、R及びRは、同一又は異なって、水素原子、アルキル、-[CHCH2-k(CHO]-H、又は-CHCH(OH)CHOC2j+1を表す。ただし、-CHCH(OH)CHOC2j+1が必ず含まれる。
 nは100~10000の整数である。
 kは0又は1である。
 mは1~10の整数である。
 jは6~26の整数である。〕
で表される会合性増粘剤である。
Figure JPOXMLDOC01-appb-C000001
[In the formula, R 1 , R 2 and R 3 are the same or different, hydrogen atom, alkyl,-[CH 2 CH 2-k (CH 3 ) k O] m -H, or -CH 2 CH (OH). ) CH 2 OC j H 2j + 1 . However, -CH 2 CH (OH) CH 2 OC j H 2j + 1 is always included.
n is an integer of 100 to 10000.
k is 0 or 1.
m is an integer from 1 to 10.
j is an integer of 6 to 26. ]
It is an associative thickener represented by.
 疎水化変性アルキルセルロースは、好ましくは、
 アルキルを10~50質量%、
 -[CHCH2-k(CHO]-Hを3~20質量%、及び
 -CHCH(OH)CHOC2j+1を0.1~10質量%、含むものである。
 疎水化変性アルキルセルロースは、更に好ましくは、jが18であるものである。
 疎水化変性アルキルセルロースとして、ヒドロキシプロピルメチルセルロースステアロキシエーテル(例えば、サンジェロース(登録商標)(大同化成工業社製))等を好適に使用することができる。
The hydrophobized modified alkyl cellulose is preferably
Alkyl is 10 to 50% by mass,
-[CH 2 CH 2-k (CH 3 ) k O] m -H is contained in an amount of 3 to 20% by mass, and -CH 2 CH (OH) CH 2 OC j H 2j + 1 is contained in an amount of 0.1 to 10% by mass. ..
The hydrophobized modified alkyl cellulose is more preferably one in which j is 18.
As the hydrophobized modified alkyl cellulose, hydroxypropylmethyl cellulose stearoxy ether (for example, Sangelose (registered trademark) (manufactured by Daido Kasei Kogyo Co., Ltd.)) and the like can be preferably used.
 疎水性変性ポリエーテルウレタンとしては、WO2018/088312に記載されたものが挙げられ、式(2):
-{(O-R-OCONH-R[-NHCOO-(R-O)-R
〔式中、R、R及びRは、それぞれ独立に炭素原子数2~4の炭化水素基である。
 Rはウレタン結合を有していてもよい炭素原子数1~10の炭化水素基である。
 Rは炭素原子数8~36の炭化水素基である。
 mは2以上の数である。
 hは1以上の数である。
 kは1~500の数である。
 nは1~200の数である。〕
で表される会合性増粘剤である。
Examples of the hydrophobically modified polyether urethane include those described in WO2018 / 088312, and the formula (2):
R 1 -{(OR 2 ) k -OCONH-R 3 [-NHCOO- (R 4 -O) n -R 5 ] h } m
[In the formula, R 1 , R 2 and R 4 are each independently a hydrocarbon group having 2 to 4 carbon atoms.
R 3 is a hydrocarbon group having 1 to 10 carbon atoms which may have a urethane bond.
R5 is a hydrocarbon group having 8 to 36 carbon atoms.
m is a number of 2 or more.
h is a number of 1 or more.
k is a number from 1 to 500.
n is a number from 1 to 200. ]
It is an associative thickener represented by.
 疎水性変性ポリエーテルウレタンとして、(PEG-240/デシルテトラデセス-20/ヘキサメチルジイソシアネート)コポリマー(例えば、アデカノール(登録商標)GT-700(ADEKA社製))等を使用することができる。 As the hydrophobically modified polyether urethane, a (PEG-240 / decyltetradeceth-20 / hexamethyldiisocyanate) copolymer (for example, Adecanol (registered trademark) GT-700 (manufactured by ADEKA)) or the like can be used.
 会合性増粘剤として、好ましくは(a)ノニオン型両親媒性ポリマーが挙げられ、より好ましくは、疎水化変性アルキルセルロース、疎水性変性ポリエーテルウレタン等が挙げられ、更に好ましくはヒドロキシプロピルメチルセルロースステアロキシエーテル、(PEG-240/デシルテトラデセス-20/ヘキサメチルジイソシアネート)コポリマー等が挙げられ、更により好ましくは、ヒドロキシプロピルメチルセルロースステアロキシエーテルが挙げられる。 Examples of the associative thickener include (a) a nonionic amphoteric polymer, more preferably a hydrophobic modified alkyl cellulose, a hydrophobic modified polyether urethane, and the like, and further preferably hydroxypropylmethyl cellulose steer. Examples thereof include rhoxyethers, (PEG-240 / decyltetradeceth-20 / hexamethyldiisocyanate) polymers, and even more preferably hydroxypropylmethylcellulose stearoxy ethers.
 高濃度のヒアルロン酸等を含有するゲル状組成物でも、経時的な安定性が得られることから、ゲル状組成物中に、0.05質量%以上の会合性増粘剤が含有される。好ましい含有量としては、0.05~1質量%が挙げられ、より好ましくは、0.06~0.5質量%が挙げられ、更に好ましくは0.07~0.3質量%が挙げられる。
 高濃度のヒアルロン酸等を含有するゲル状組成物でも、経時的な安定性が得られることから、(B)アニオン性高分子化合物増粘剤と(C)会合性増粘剤の質量比は、5:1~0.15:1である。質量比は、好ましくは4:1~1:1であり、より好ましくは3.5:1~1.2:1である。質量比が上記範囲であることで、本発明のゲル状組成物のゲルが均一となり、むらの発生が抑えられる。
Even in a gel-like composition containing a high concentration of hyaluronic acid or the like, stability over time can be obtained. Therefore, 0.05% by mass or more of an associative thickener is contained in the gel-like composition. Preferred contents include 0.05 to 1% by mass, more preferably 0.06 to 0.5% by mass, and further preferably 0.07 to 0.3% by mass.
Since stability over time can be obtained even in a gel-like composition containing a high concentration of hyaluronic acid or the like, the mass ratio of (B) anionic polymer compound thickener to (C) associative thickener is It is 5: 1 to 0.15: 1. The mass ratio is preferably 4: 1 to 1: 1 and more preferably 3.5: 1 to 1.2: 1. When the mass ratio is in the above range, the gel of the gel-like composition of the present invention becomes uniform and the occurrence of unevenness is suppressed.
<油分>
 本発明のゲル状組成物は、肌なじみ向上効果等を高める点で油分を5質量%以上20質量%以下含有することができる。本発明のゲル状組成物に使用する油分は、化粧料等に使用できる油溶性原料であれば特に制限されるものではないが、例えば、ラウロイルグルタミンサンジ(オクチルドデシルスラッシュフィトステリル)、植物性スクワラン、マカデミアンオイル、d-δ-トコフェロール、トリオクタノイン、乳酸セチル、2-エチルヘキサン酸セチル、フィトスクワラン、流動パラフィン、スクワラン、ミツロウ、ワセリン、ラノリン、カルナバロウ、オリーブ油、アボガド油、ツバキ油、ホホバ油、馬油、ミンク油、セラミド、コエンザイムQ10、パルミチン酸レチノール、パンテノール、卵黄レシチン、大豆レシチン、水添レシチン、ポリソルベート-60、フィトステロール、トリエチルヘキサノイン、グリセロールモノステアレート、ポリオキシエチレンモノステアレート、ステアリルアルコール、ソルビタンステアレート、セトステアリルアルコール、ポリオキシエチレンセトステアリルアルコール、ポリオキシエチレン脂肪酸エステル、ステアリン酸ポリグリセリル-10、ポリオキシエチレン硬化ヒマシ油誘導体、カプリル酸グリセリン、高級脂肪酸(ラウリン酸、ベヘニン酸、パルミチン酸、ステアリン酸、イソステアリン酸、オレイン酸、リノール酸、高級脂肪酸塩等)、シリコーン及びシリコーン誘導体(ジメチルポリシロキサン、環状ジメチルポリシロキサン、メチルフェニルポリシロキサン、シリコーンレジン、ポリエーテル変性シリコーン、アミノ変性シリコーン等)等が挙げられる。
<Oil>
The gel-like composition of the present invention can contain 5% by mass or more and 20% by mass or less of oil in terms of enhancing the effect of improving skin compatibility. The oil content used in the gel-like composition of the present invention is not particularly limited as long as it is an oil-soluble raw material that can be used in cosmetics and the like. Squalane, Macademian oil, d-δ-tocopherol, trioctanoin, cetyl lactate, cetyl 2-ethylhexanate, phytosqualane, liquid paraffin, squalane, beeswax, vaseline, lanolin, carnauba wax, olive oil, avocado oil, camellia oil, jojoba Oil, horse oil, mink oil, ceramide, coenzyme Q10, retinol palmitate, pantenol, egg yolk lecithin, soy lecithin, hydrogenated lecithin, polysorbate-60, phytosterol, triethylhexanoin, glycerol monostearate, polyoxyethylene monostea Rate, stearyl alcohol, sorbitan stearate, cetostearyl alcohol, polyoxyethylene cetostearyl alcohol, polyoxyethylene fatty acid ester, polyglyceryl-10 stearate, polyoxyethylene hydrogenated castor oil derivative, glycerin caprylate, higher fatty acid (lauric acid, Behenic acid, palmitic acid, stearic acid, isostearic acid, oleic acid, linoleic acid, higher fatty acid salts, etc.), silicone and silicone derivatives (dimethylpolysiloxane, cyclic dimethylpolysiloxane, methylphenylpolysiloxane, silicone resin, polyether-modified silicone) , Amino-modified silicone, etc.) and the like.
<その他の成分>
 本発明のゲル状組成物には、水が溶剤として含まれる。更に、本発明のゲル状組成物は、その他の成分として、一般的に化粧料等に配合される成分等をその目的に適した量で含むことができる。その他の成分としては、例えば、界面活性剤(アニオン性界面活性剤、ノニオン性界面活性剤、カチオン性界面活性剤、両性界面活性剤)、保湿剤、機能性成分、天然物エキス、タンパク質加水分解物、アミノ酸、カチオン化多糖類、高級アルコール、多価アルコール、両性高分子樹脂化合物、カチオン性高分子樹脂化合物、防腐剤、酸化防止剤、金属封鎖剤、紫外線吸収剤、紫外線反射剤、pH調整剤、香料、色素が挙げられる。
<Other ingredients>
The gel-like composition of the present invention contains water as a solvent. Further, the gel-like composition of the present invention can contain, as other components, components generally blended in cosmetics and the like in an amount suitable for the purpose. Other components include, for example, surfactants (anionic surfactants, nonionic surfactants, cationic surfactants, amphoteric surfactants), moisturizers, functional ingredients, natural product extracts, protein hydrolysis. Substances, amino acids, cationized polysaccharides, higher alcohols, polyhydric alcohols, amphoteric polymer resin compounds, cationic polymer resin compounds, preservatives, antioxidants, metal sequestering agents, UV absorbers, UV reflectors, pH adjustment Examples include agents, fragrances and pigments.
 アニオン性界面活性剤としては、例えば、アルキルベンゼンスルホン酸塩、ポリオキシアルキレンアルキルエーテル硫酸エステル塩、アルキル硫酸エステル塩、オレフィンスルホン酸塩、ジアルキルスルホコハク酸塩等が挙げられる。
 ノニオン性界面活性剤としては、例えば、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油誘導体等が挙げられる。
 カチオン性界面活性剤としては、例えば、アルキルトリメチルアンモニウム塩、ジアルキルジメチルアンモニウム塩、アルキルピリジニウム塩、塩化ステアリルトリメチルアンモニウム等が挙げられる。
 両性界面活性剤としては、例えば、アルキルベタイン、アルキルアミドプロピルベタイン、イミダゾリニウムベタイン、卵黄レシチン、大豆レシチン等が挙げられる。
 保湿剤としては、例えば、ラウロイルグルタミン酸ジフィトステリルオクチルドデシル、フィトグリコーゲン、加水分解卵殻膜、トレハロース、アテロコラーゲン、ソルビトール、マルチトール等が挙げられる。
Examples of the anionic surfactant include alkylbenzene sulfonates, polyoxyalkylene alkyl ether sulfate esters, alkyl sulfate ester salts, olefin sulfonates, dialkyl sulfosuccinates and the like.
Examples of the nonionic surfactant include polyoxyethylene fatty acid ester, polyoxyethylene hydrogenated castor oil derivative and the like.
Examples of the cationic surfactant include alkyltrimethylammonium salt, dialkyldimethylammonium salt, alkylpyridinium salt, stearyltrimethylammonium chloride and the like.
Examples of the amphoteric tenside include alkyl betaine, alkylamide propyl betaine, imidazolinium betaine, egg yolk lecithin, soybean lecithin and the like.
Examples of the moisturizer include diphytosteryl octyldodecyl lauroyl glutamate, phytoglycogen, hydrolyzed eggshell membrane, trehalose, atelocollagen, sorbitol, maltitol and the like.
 機能性成分としては、例えば、アルブチン、ポリクオタニウム51、エラスチン、白金ナノコロイド、アラントイン、ジラウロイルグルタミン酸リシンナトリウム、リン酸アスコルビルマグネシウム、L-アスコルビン酸2-グルコシド、エラグ酸、コウジ酸、ビタミンA油、レチノール、パルミチン酸レチノール、イノシット、塩酸ピリドキシン、ニコチン酸ベンジル、ニコチン酸アミド、ニコチン酸dl-α-トコフェロール、ビタミンD2(エルゴカシフェロール)、dl-α-トコフェロール、酢酸dl-α-トコフェロール、パントテン酸、ビオチン等のビタミン類、エストラジオール、エチニルエストラジオール等のホルモンアラントイン、トラネキサム酸、グリチルレチン酸、アズレン酸の抗炎症剤等が挙げられる。 Examples of the functional component include albutin, polyquaternium 51, elastin, platinum nanocolloid, allantin, sodium dilauroyl glutamate lysine, ascorbic magnesium phosphate, L-ascorbic acid 2-glucoside, ellagic acid, niacin, vitamin A oil, and the like. Retinol, retinol palmitate, innosit, pyridoxin hydrochloride, benzyl nicotinate, nicotinic acid amide, dl-α-tocopherol nicotinate, vitamin D2 (ergocasiferol), dl-α-tocopherol, dl-α-tocopherol acetate, pantothenic acid , Vitamins such as biotin, hormone allantin such as estradiol and ethynyl estradiol, anti-inflammatory agents such as tranexamic acid, glycyrrhetinic acid and azulene acid.
 天然物エキスとしては、例えば、クジンエキス、カジルエキス、海藻エキス、ユーカリエキス、ローヤルゼリーエキス、ローズマリーエキス、ブナの木エキス、アセンヤクエキス、ブナノメエキス、ウコンエキス、ドクダミエキス、オウバクエキス、メリロートエキス、オドリコソウエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、キナエキス、ユキノシタエキス、クララエキス、コウホネエキス、ウイキョウエキス、サクラソウエキス、バラエキス、ジオウエキス、レモンエキス、シコンエキス、アロエエキス、ショウブ根エキス、ユーカリエキス、スギナエキス、セージエキス、タイムエキス、茶エキス、キューカンバーエキス、チョウジエキス、キイチゴエキス、メリッサエキス、ニンジンエキス、カロットエキス、マロニエエキス、モモエキス、桃葉エキス、クワエキス、ヤグルマギクエキス、ハマメリス抽出液、プラセンタエキス、胸線抽出物、シルク抽出液等が挙げられる。 Natural product extracts include, for example, Kujin extract, Kazil extract, Seaweed extract, Eucalyptus extract, Royal jelly extract, Rosemary extract, Beech tree extract, Asenyaku extract, Bunanome extract, Ukon extract, Dokudami extract, Oubaku extract, Merilot extract, Odorikosou extract. , Kanzo extract, Shakuyaku extract, Sabonsou extract, Hechima extract, Kina extract, Yukinoshita extract, Clara extract, Kohone extract, Uikyo extract, Sakurasou extract, Rose extract, Dio extract, Lemon extract, Shikon extract, Aloe extract, Shobu root extract, Eucalyptus extract, Sugina extract, sage extract, thyme extract, tea extract, cucumber extract, butterfly extract, strawberry extract, melissa extract, carrot extract, carrot extract, marronnier extract, peach extract, peach leaf extract, kuwa extract, yagurumagiku extract, hamamelis extract, placenta extract, Chest line extract, silk extract and the like can be mentioned.
 タンパク質加水分解物としては、例えば、ケラチンペプチド、コラーゲンペプチド、大豆ペプチド、コムギペプチド、ミルクペプチド、シルクペプチド、卵白ペプチド、加水分解卵殻膜等が挙げられる。
 アミノ酸としては、例えば、アルギニン、グルタミン酸、グリシン、アラニン、ヒドロキシプロリン、システイン、セリン、L-テアニン等が挙げられる。
 カチオン化多糖類としては、例えば、カチオン化ヒドロキシエチルセルロース、カチオン化グアーガム、カチオン化澱粉、カチオン化ローカストビーンガム、カチオン化デキストラン、カチオン化キトサン、カチオン化ハチミツ等が挙げられる。
 高級アルコールとしては、例えば、セチルアルコール、ベヘニルアルコール、イソステアリルアルコール、バチルアルコール等が挙げられる。
 多価アルコールとしては、例えば、プロピレングリコール、ポリエチレングリコール、ペンチレングリコール、カプリリルグリコール、ヘキサンジオール、エチルヘキシルグルセリン、1,3-ブチレングリコール、1,3-プロパンジオール、ジグリセリン、グリセリン等が挙げられる。
Examples of the protein hydrolyzate include keratin peptide, collagen peptide, soybean peptide, wheat peptide, milk peptide, silk peptide, egg white peptide, hydrolyzed eggshell membrane and the like.
Examples of amino acids include arginine, glutamic acid, glycine, alanine, hydroxyproline, cysteine, serine, L-theanine and the like.
Examples of the cationized polysaccharide include cationized hydroxyethyl cellulose, cationized guar gum, cationized starch, cationized locust bean gum, cationized dextran, cationized chitosan, cationized honey and the like.
Examples of the higher alcohol include cetyl alcohol, behenyl alcohol, isostearyl alcohol, bacillic alcohol and the like.
Examples of the polyhydric alcohol include propylene glycol, polyethylene glycol, pentylene glycol, caprylyl glycol, hexanediol, ethylhexyl gluserine, 1,3-butylene glycol, 1,3-propanediol, diglycerin, glycerin and the like. Be done.
 両性高分子樹脂化合物としては、例えば、ベタイン化ジアルキルアミノアルキルアクリレート共重合体等が挙げられる。
 カチオン性高分子樹脂化合物としては、例えば、ビニルピロリドン/ジメチルアミノエチルメタクリレート共重合体カチオン化物、ポリジメチルジアリルアンモニウムハライド型カチオン性ポリマー等が挙げられる。
 防腐剤としては、例えば、メチルパラベン、エチルパラベン、ブチルパラベン、プロピルパラベン、フェノキシエタノール等が挙げられる。
 酸化防止剤としては、例えば、トコフェノール、BHT等が挙げられる。
 金属封鎖剤としては、例えば、EDTA-2Na、EDTA-4Na、エデト酸塩、エチドロン酸塩等が挙げられる。
 紫外線吸収剤としては、例えば、ベンゾフェノン誘導体、パラアミノ安息香酸誘導体、メトキシ桂皮酸誘導体等が挙げられる。
 紫外線反射剤としては、例えば、酸化チタン、酸化亜鉛等が挙げられる。
Examples of the amphoteric polymer resin compound include betaineized dialkylaminoalkyl acrylate copolymers.
Examples of the cationic polymer resin compound include vinylpyrrolidone / dimethylaminoethyl methacrylate copolymer cationized products, polydimethyldiallyl ammonium halide-type cationic polymers, and the like.
Examples of the preservative include methylparaben, ethylparaben, butylparaben, propylparaben, phenoxyethanol and the like.
Examples of the antioxidant include tocopherol, BHT and the like.
Examples of the metal sequestering agent include EDTA-2Na, EDTA-4Na, edetate, etidronate and the like.
Examples of the ultraviolet absorber include a benzophenone derivative, a para-aminobenzoic acid derivative, a methoxycinnamic acid derivative and the like.
Examples of the ultraviolet reflector include titanium oxide, zinc oxide and the like.
 pH調整剤として、例えば、水酸化ナトリウム等のアルカリ水酸化物等、及び塩酸、硫酸、リン酸、メタンスルホン酸等の酸が挙げられる。pH調整剤を用いて、本発明のゲル状組成物のpHを好ましくはpH5~7.5、より好ましくはpH6~7に調整することができる。 Examples of the pH adjuster include alkaline hydroxides such as sodium hydroxide and acids such as hydrochloric acid, sulfuric acid, phosphoric acid and methanesulfonic acid. The pH of the gelled composition of the present invention can be adjusted to preferably pH 5 to 7.5, more preferably pH 6 to 7, using a pH adjuster.
2.ゲル状組成物の製造方法及び用途
 本発明のゲル状組成物は、常法に従って製造することができる。例えば、上記各成分を増粘剤と共に混合してゲル化することで製造することができる。製造されたゲル状組成物は、用途に応じて、容器等に充填密封される。
 本発明のゲル状組成物は、オールインワン化粧料等の高粘度の化粧料及び毛髪化粧料等として、好適に用いることができる。
2. 2. Methods and Applications for Producing Gel-like Composition The gel-like composition of the present invention can be produced according to a conventional method. For example, it can be produced by mixing each of the above components with a thickener and gelling. The produced gel-like composition is filled and sealed in a container or the like according to the intended use.
The gel-like composition of the present invention can be suitably used as a high-viscosity cosmetic such as an all-in-one cosmetic and a hair cosmetic.
 以下、本発明を実施例により更に詳細に説明するが、本発明はこれらに何ら限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.
実施例1~16及び比較例1~4
<ゲル状組成物の調製>
 表1~表4に記載された各成分(質量%)をイオン交換水(残余)に添加して混合し、必要に応じて水酸化ナトリウム水溶液を添加してpHを6~7.5に調整することで、実施例1~16及び比較例1~4のゲル状組成物を調製した。
Examples 1 to 16 and Comparative Examples 1 to 4
<Preparation of gel-like composition>
Each component (mass%) shown in Tables 1 to 4 is added to ion-exchanged water (residual) and mixed, and if necessary, an aqueous sodium hydroxide solution is added to adjust the pH to 6 to 7.5. By doing so, the gel-like compositions of Examples 1 to 16 and Comparative Examples 1 to 4 were prepared.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
 上記実施例及び比較例で用いた材料は、以下に示すものである。
<(A)成分>
 ヒアルロン酸Na:ヒアルロンサン HA-LQ(キユーピー社製),平均分子量85万~160万
 加水分解ヒアルロン酸アルキル(C12-13)グリセリル:ヒアロリペア(登録商標)(キユーピー社製),平均分子量1万以下
 カルボキシメチルヒアルロン酸Na:ヒアロキャッチ(登録商標)(キユーピー社製),平均分子量80万~120万
 加水分解ヒアルロン酸Na:HAbooster(登録商標)(キユーピー社製),平均分子量1000~3500
 ヒアルロン酸ヒドロキシプロピルトリモニウム:ヒアロベール-P(登録商標)(キユーピー社製),平均分子量50万~80万
 加水分解ヒアルロン酸:ヒアロオリゴ(登録商標)(キユーピー社製),平均分子量1万以下
The materials used in the above Examples and Comparative Examples are as shown below.
<Ingredient (A)>
Na hyaluronate: Hyaluronsan HA-LQ (manufactured by Kewpie), average molecular weight 850,000 to 1.6 million Hydrolyzed alkyl hyaluronate (C12-13) Glyceryl: Hyalo Repair (registered trademark) (manufactured by Kewpie), average molecular weight 10,000 or less Carboxy Na Methylhyaluronate: Hyalocatch (registered trademark) (manufactured by Kewpie), average molecular weight 800,000 to 1.2 million Hydrolyzed Na Na hyaluronate (registered trademark) (manufactured by Kewpie), average molecular weight 1000 to 3500
Hydroxypropyltrimonium hyaluronate: Hyalover-P (registered trademark) (manufactured by Kewpie), average molecular weight of 500,000 to 800,000 Hydrolyzed hyaluronic acid: hyalooligo (registered trademark) (manufactured by Kewpie), average molecular weight of 10,000 or less
<(B)成分>
 (アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー:Pemulen(登録商標)TR-1(Lubrizol社製)
 アクリレーツコポリマー:Carbopol(R) Aqua SF-1 Polymer(Lubrizol Advanced Material社製)
 ポリアクリル酸Na:アロンビス MX(東亞合成社製)
 (アクリロイルジメチルタウリンアンモニウムメタクリル酸ベヘネス-25)クロスポリマー:アリストフレックス HMB(クラリアントジャパン社製)
 アルギン酸Na:キミカアルギン I-3(キミカ社製)
 カルボキシメチルセルロースNa:CMCダイセル 1350(ダイセルファインケム社製)
 カラギーナン:GENUGEL(CP Kelco社製)
 カルボマー:CARBOPOL(登録商標)ULTREZ 10(Lubrizol Advanced Material社製)
<Ingredient (B)>
(Acrylate / Alkyl acrylate (C10-30)) Crosspolymer: Pemulen (registered trademark) TR-1 (manufactured by Lubrizol)
Acrylate Copolymer: Carbopol (R) Aqua SF-1 Polymer (manufactured by Lubrizol Advanced Material)
Sodium polyacrylate: Aronbis MX (manufactured by Toagosei Co., Ltd.)
(Acryloyldimethyltaurine ammonium methacrylate Behenes-25) Crosspolymer: Aristoflex HMB (manufactured by Clariant Japan)
Na alginate: Kimika algin I-3 (manufactured by Kimika)
Carboxymethyl Cellulose Na: CMC Daicel 1350 (manufactured by Daicel FineChem)
Carrageenan: GENUGEL (manufactured by CP Kelco)
Carbomer: CARBOPOL® (registered trademark) ULTREZ 10 (manufactured by Lubrizol Advanced Material)
<(C)成分>
 ヒドロキシプロピルメチルセルロースステアロキシエーテル:サンジェロース(登録商標)(大同化成工業社製)
 (PEG-240/デシルテトラデセス-20/HDI)コポリマー:アデカノール GT-700(登録商標)(ADEKA社製)
<油分>
 油分として、スクワラン、パルミチン酸エチルヘキシル及びマカデミア種子油等を用いた。
<グリコール類>
 グリコール類として、ブチレングリコール、ペンチレングリコール及びグリセリンを用いた。
<Ingredient (C)>
Hydroxypropyl Methyl Cellulose Stearoxy Ether: Sangelose (registered trademark) (manufactured by Daido Kasei Kogyo Co., Ltd.)
(PEG-240 / decyltetradeceth-20 / HDI) copolymer: Adecanol GT-700® (registered trademark) (manufactured by ADEKA)
<Oil>
As the oil content, squalane, ethylhexyl palmitate, macadamia seed oil and the like were used.
<Glycols>
Butylene glycol, pentylene glycol and glycerin were used as glycols.
試験例
<ゲル状組成物の評価>
(粘度)
 ゲル状組成物の粘度は、ゲル状組成物を調製した翌日に測定した。粘度(mPa・s)は、B型粘度計(Viscometer BLII,東機産業社製)を用いて、Rotor No.4で、6rpm、60秒間、25℃で測定した。
(pH)
 ゲル状組成物のpHは、ゲル状組成物を調製した翌日に測定した。pHは、pHメーター(HORIBA社製)を用いて測定した。
Test Example <Evaluation of gel-like composition>
(viscosity)
The viscosity of the gel-like composition was measured the day after the gel-like composition was prepared. The viscosity (mPa · s) was determined by using a B-type viscometer (Viscometer BLII, manufactured by Toki Sangyo Co., Ltd.) to obtain Rotor No. At 4, the measurement was performed at 25 ° C. at 6 rpm for 60 seconds.
(PH)
The pH of the gel-like composition was measured the day after the gel-like composition was prepared. The pH was measured using a pH meter (manufactured by HORIBA).
(安定性)
 ゲル状組成物の安定性は、ゲル状組成物を調製し、室温で6ヶ月経過後に、下記の指標に従って評価した。
 ○:良好
 △:少しゲルの不均一化が確認される
 ×:ゲルが完全に不均一であり、ムラが生じる
(Stability)
The stability of the gel-like composition was evaluated according to the following index after 6 months had passed since the gel-like composition was prepared.
◯: Good △: Gel non-uniformity is confirmed a little ×: Gel is completely non-uniform and unevenness occurs
(総合使用感)
 ゲル状組成物の使用感は、以下の評価項目及び指標に従って、任意に選択したボランティア5名によって、総合評価した。
・評価項目
 塗布時の肌へののび、適度な厚み
 塗布後のべとつきの無さ
・指標
 ◎:極めて良好
 ○:良好
 △:中程度
 ×:不良(不良であった項目は欄外に記載する)
(Comprehensive usability)
The usability of the gel-like composition was comprehensively evaluated by 5 volunteers arbitrarily selected according to the following evaluation items and indicators.
・ Evaluation items Spread on the skin at the time of application, moderate thickness No stickiness after application ◎: Very good ○: Good △: Medium ×: Defective (Items that were defective are listed in the margin)
 実施例1~16及び比較例1~4のゲル状組成物の評価の結果を表5に示す。 Table 5 shows the results of evaluation of the gelled compositions of Examples 1 to 16 and Comparative Examples 1 to 4.
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
 表5から分かるように、粘度については、実施例1~16のゲル状組成物ではすべて15000~60000mPa・sの範囲に含まれ、高粘度のゲル状組成物であった。(B)成分として、アニオン性合成高分子化合物増粘剤を用いる実施例1~9及び14~16では、粘度が24000~42500mPa・sであり、例えばオールインワン化粧料等としても使用しうるより好適な粘度を有している。アニオン性天然高分子化合物増粘剤を用いる実施例10~12では、粘度が17800~20500mPa・sと低かった。このように、(B)アニオン性高分子化合物増粘剤において、アニオン性合成高分子化合物増粘剤がより好ましいことが分かる。また、例えば、実施例1~4を比較することで、(B)成分の含有量が増えるほど、粘度が上昇することが分かる。 As can be seen from Table 5, all of the gel-like compositions of Examples 1 to 16 were contained in the range of 15,000 to 60,000 mPa · s, and were highly viscous gel-like compositions. In Examples 1 to 9 and 14 to 16 in which an anionic synthetic polymer compound thickener is used as the component (B), the viscosity is 24000 to 42,500 mPa · s, which is more suitable than that it can be used as, for example, all-in-one cosmetics. Has a good viscosity. In Examples 10 to 12 using the anionic natural polymer compound thickener, the viscosity was as low as 17800 to 20500 mPa · s. As described above, it can be seen that the anionic synthetic polymer compound thickener is more preferable in the (B) anionic polymer compound thickener. Further, for example, by comparing Examples 1 to 4, it can be seen that the viscosity increases as the content of the component (B) increases.
 安定性については、(B)アニオン性高分子化合物増粘剤と(C)会合性増粘剤の質量比が5:1~0.15:1である実施例1~16では、良好又少しゲルの不均一化が確認される程度であり、本発明のゲル状組成物として用いられうるものであった。他方、(B)アニオン性高分子化合物増粘剤のみを用いる比較例1及び2、(C)会合性増粘剤のみを用いる比較例3及び4では、ゲルが不均一となり、経時的な安定性が不満足であり、更には使用感も不十分であった。なお、比較例1及び3では粘度が低かったため、それぞれの増粘剤の含有量を増やしたものが比較例2及び4であるが、安定性は同様に不満足であり、肌へののび及びべとつきがより悪化した。 Regarding stability, in Examples 1 to 16 in which the mass ratio of (B) anionic polymer compound thickener and (C) associative thickener is 5: 1 to 0.15: 1, it is good or slightly. The non-uniformity of the gel was confirmed, and it could be used as the gel-like composition of the present invention. On the other hand, in Comparative Examples 1 and 2 using only the (B) anionic polymer compound thickener and Comparative Examples 3 and 4 using only the (C) associative thickener, the gel became non-uniform and stable over time. The sex was unsatisfactory, and the feeling of use was also insufficient. Since the viscosities of Comparative Examples 1 and 3 were low, those in which the content of each thickener was increased were Comparative Examples 2 and 4, but the stability was also unsatisfactory, and the skin was spread and sticky. Was worse.
 使用感については、(B)成分として、(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマーを用いる実施例1~6のゲル状組成物が、使用感の総合評価で好ましい結果を与えた。従って、(B)アニオン性高分子化合物増粘剤において、(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー等のアクリル酸系アニオン性高分子化合物増粘剤がより好適であることが分かる。 Regarding the feeling of use, the gelled compositions of Examples 1 to 6 using the (Acrylate / alkyl acrylate (C10-30)) crosspolymer as the component (B) gave favorable results in the comprehensive evaluation of the feeling of use. .. Therefore, it can be seen that in the (B) anionic polymer compound thickener, an acrylic acid-based anionic polymer compound thickener such as (Acrylate / alkyl acrylate (C10-30)) crosspolymer is more suitable. ..
 今回開示された実施の形態及び実施例はすべての点で例示であって制限的なものではない。本発明の範囲は、上記の説明ではなく、特許請求の範囲によって示され、特許請求の範囲と均等の意味及び範囲内でのすべての変更が含まれる。 The embodiments and examples disclosed this time are exemplary in all respects and are not restrictive. The scope of the present invention is shown by the scope of claims, not the above description, and includes all modifications within the meaning and scope equivalent to the scope of claims.
 本発明によって、経時的な安定性を有し、経時的にゲルの不均一化がなく、だまになりにくい、0.2質量%以上の高濃度のヒアルロン酸等を含有する高粘度のゲル状組成物が提供される。 According to the present invention, it is in the form of a highly viscous gel containing hyaluronic acid or the like having a high concentration of 0.2% by mass or more, which has stability over time, does not cause non-uniformity of the gel over time, and is less likely to be fooled. The composition is provided.

Claims (5)

  1.  (A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩を0.2質量%以上含有し、粘度が15000~60000mPa・sである、ゲル状組成物であって、
     前記ゲル状組成物は、(B)アニオン性高分子化合物増粘剤(ただし、(A)成分を除く)を0.1質量%以上、(C)会合性増粘剤を0.05質量%以上含有し、
     (B)アニオン性高分子化合物増粘剤は、(A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩以外のアニオン性高分子化合物増粘剤であり、
     (B)アニオン性高分子化合物増粘剤と(C)会合性増粘剤の質量比が、5:1~0.15:1である、ゲル状組成物。
    (A) A gel-like composition containing 0.2% by mass or more of hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof and having a viscosity of 15,000 to 60,000 mPa · s.
    The gel-like composition contains (B) anionic polymer compound thickener (however, excluding (A) component) in an amount of 0.1% by mass or more, and (C) an associative thickener in an amount of 0.05% by mass. Contains more than
    The (B) anionic polymer compound thickener is an anionic polymer compound thickener other than (A) hyaluronic acid and / or a hyaluronic acid derivative or a salt thereof.
    A gel-like composition in which the mass ratio of the (B) anionic polymer compound thickener to the (C) associative thickener is 5: 1 to 0.15: 1.
  2.  (C)会合性増粘剤が疎水化変性アルキルセルロースである、請求項1に記載のゲル状組成物。 (C) The gel-like composition according to claim 1, wherein the associative thickener is hydrophobized modified alkyl cellulose.
  3.  (A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩からなる群から選択される1つ以上のうち、平均分子量が50万~200万であるものを0.1質量%以上含有する、請求項1又は2に記載のゲル状組成物。 (A) Claimed to contain 0.1% by mass or more of one or more selected from the group consisting of hyaluronic acid and / or hyaluronic acid derivatives or salts thereof, having an average molecular weight of 500,000 to 2,000,000. Item 2. The gel-like composition according to Item 1 or 2.
  4.  (A)ヒアルロン酸及び/若しくはヒアルロン酸誘導体又はそれらの塩からなる群から選択される1つ以上のうち、平均分子量が50万~200万であるものを0.1質量%以上含有し、平均分子量が1万以下であるものを0.1質量%以上含有する、請求項1又は2に記載のゲル状組成物。 (A) Among one or more selected from the group consisting of hyaluronic acid and / or hyaluronic acid derivatives or salts thereof, those having an average molecular weight of 500,000 to 2 million are contained in an average of 0.1% by mass or more. The gel-like composition according to claim 1 or 2, which contains 0.1% by mass or more of a composition having a molecular weight of 10,000 or less.
  5.  粘度が25000~45000mPa・sである、請求項1~4のいずれかに記載のゲル状組成物。 The gel-like composition according to any one of claims 1 to 4, which has a viscosity of 25,000 to 45,000 mPa · s.
PCT/JP2021/029367 2020-08-28 2021-08-06 Gel composition WO2022044781A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020-144639 2020-08-28
JP2020144639A JP7104942B2 (en) 2020-08-28 2020-08-28 gel composition

Publications (1)

Publication Number Publication Date
WO2022044781A1 true WO2022044781A1 (en) 2022-03-03

Family

ID=80353168

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/029367 WO2022044781A1 (en) 2020-08-28 2021-08-06 Gel composition

Country Status (2)

Country Link
JP (1) JP7104942B2 (en)
WO (1) WO2022044781A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06287107A (en) * 1993-03-31 1994-10-11 Sunstar Inc Gel-like emulsion cosmetic
JP2011513481A (en) * 2008-03-13 2011-04-28 バイオランド エルティディ Anti-aging composition containing polysaccharide extracted from low and high molecular weight hyaluronic acid and persimmon root bark
WO2013125634A1 (en) * 2012-02-22 2013-08-29 株式会社ヒアルロン酸研究所 Tlr4 agent, tissue homeostasis agent, hepatocyte growth factor inducer, tissue repairing agent, and sirtuin inducer having hyaluronic acid fragments as active ingredients thereof
JP2013170149A (en) * 2012-02-22 2013-09-02 Hyaluronan Kenkyusho:Kk Extracellular substrate formation-promoting agent containing hyaluronic acid oligosaccharide as active ingredient
JP2013249259A (en) * 2012-05-30 2013-12-12 Kao Corp Gel-like fragrance composition
JP2019044086A (en) * 2017-09-04 2019-03-22 大日精化工業株式会社 Manufacturing method of medical and cosmetic material, and medical and cosmetic material
JP2019214537A (en) * 2018-06-14 2019-12-19 日本精化株式会社 Phosphatidylinositol-containing cosmetic or external preparation for skin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06287107A (en) * 1993-03-31 1994-10-11 Sunstar Inc Gel-like emulsion cosmetic
JP2011513481A (en) * 2008-03-13 2011-04-28 バイオランド エルティディ Anti-aging composition containing polysaccharide extracted from low and high molecular weight hyaluronic acid and persimmon root bark
WO2013125634A1 (en) * 2012-02-22 2013-08-29 株式会社ヒアルロン酸研究所 Tlr4 agent, tissue homeostasis agent, hepatocyte growth factor inducer, tissue repairing agent, and sirtuin inducer having hyaluronic acid fragments as active ingredients thereof
JP2013170149A (en) * 2012-02-22 2013-09-02 Hyaluronan Kenkyusho:Kk Extracellular substrate formation-promoting agent containing hyaluronic acid oligosaccharide as active ingredient
JP2013249259A (en) * 2012-05-30 2013-12-12 Kao Corp Gel-like fragrance composition
JP2019044086A (en) * 2017-09-04 2019-03-22 大日精化工業株式会社 Manufacturing method of medical and cosmetic material, and medical and cosmetic material
JP2019214537A (en) * 2018-06-14 2019-12-19 日本精化株式会社 Phosphatidylinositol-containing cosmetic or external preparation for skin

Also Published As

Publication number Publication date
JP2022039549A (en) 2022-03-10
JP7104942B2 (en) 2022-07-22

Similar Documents

Publication Publication Date Title
EP2865442B1 (en) Liquid dispersion and formation method for hydrogels
EP3056519B1 (en) Carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof and/or production method for carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof
JP5433128B2 (en) Topical skin preparation
US9107842B2 (en) Modified hyaluronic acid and/or a salt thereof, method for producing the same, and cosmetic preparation comprising the same
JP6715592B2 (en) Cosmetics containing low molecular weight cationized hyaluronic acid
JPWO2008133267A1 (en) Cationized hyaluronic acid and / or salt thereof, method for producing the same, and hair modifying agent, cuticle restorative agent, skin modifying agent and cosmetics using the same
JP2013181001A (en) Hyaluronic acid composition and skin care preparation including the same
JP2010070492A (en) Cosmetic product
JP2005330257A (en) Cosmetic
JP5107525B2 (en) Thickening composition and external preparation for skin containing the same
JP2013107862A (en) Skin cosmetic gel
WO2015053282A1 (en) Crosslinked product of carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof, and method for producing same
JP5814181B2 (en) Skin barrier function improver
JP5840838B2 (en) Thickening composition and method for producing the same
JP5734536B1 (en) Carboxymethyl group-containing modified hyaluronic acid and / or a salt thereof and a method for producing the same
WO2022044781A1 (en) Gel composition
Baptista et al. Bacterial polysaccharides: cosmetic applications
JP2016199515A (en) Emulsion cosmetic
WO2014065303A1 (en) External composition for skin
JP2016199516A (en) Gel-like cosmetic
JP2018080139A (en) Cosmetic
JP2022183243A (en) Collagen complex and method for producing cosmetic composition containing the same
JP2004107238A (en) Kit for improving dry skin
CN117597148A (en) Non-water-swellable film-forming external preparation base
JP2022000414A (en) Cosmetic or external preparation for skin containing inulin and polyhydric alcohol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21861209

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21861209

Country of ref document: EP

Kind code of ref document: A1